{
  "meta": {
    "title": "00089_Late_Night_Pyq_Pyt_Marathon_Medicine-5",
    "url": "https://brainandscalpel.vercel.app/00089-late-night-pyq-pyt-marathon-medicine-5-a744bc8c.html",
    "scrapedAt": "2025-11-29T17:25:47.783Z"
  },
  "questions": [
    {
      "id": 45513,
      "choices": [
        {
          "id": 181691,
          "text": "<p><span style=\"font-size:16px;\">Flow cytometry</span></p>"
        },
        {
          "id": 181692,
          "text": "<p><span style=\"font-size:16px;\">Sucrose hemolysis test</span></p>"
        },
        {
          "id": 181693,
          "text": "<p><span style=\"font-size:16px;\">HAM test</span></p>"
        },
        {
          "id": 181694,
          "text": "<p><span style=\"font-size:16px;\">Genetic testing</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">The gold standard test for the diagnosis of Paroxysmal Nocturnal Hemoglobinuria (PNH) is: (NEET PG 2014)</span></p>",
      "unique_key": "Q9952059",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934784,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Flow cytometry</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The gold standard diagnostic test for PNH is the flow cytometry quantification of GPI-linked proteins. This test detects the deficiency of GPI-anchored proteins, such as CD55 (DAF) and CD59 (MIRL), on the surface of red blood cells, which normally protect them from complement-mediated destruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Diagnosis of PNH:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/24/screenshot-2024-05-24-164648.png\" alt=\"\" width=\"1000\" height=\"696\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Manifestations of PNH:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/24/screenshot-2024-05-24-164701.png\" alt=\"\" width=\"1000\" height=\"396\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Sucrose Hemolysis Test:</strong> Used for screening but not the gold standard.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. HAM Test:</strong> An older test, less commonly used now.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Genetic Testing:</strong> Useful for identifying PIGA gene mutations but not the primary diagnostic tool.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Flow cytometry is the gold standard for diagnosing PNH, detecting deficiencies in CD55 and CD59 on red blood cells.</span></p>",
      "correct_choice_id": 181691,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 46785,
      "choices": [
        {
          "id": 186755,
          "text": "<p>Hypertrophic obstructive cardiomyopathy (HOCM)</p>"
        },
        {
          "id": 186756,
          "text": "<p>Aortic valve stenosis</p>"
        },
        {
          "id": 186757,
          "text": "<p>Brugada syndrome</p>"
        },
        {
          "id": 186758,
          "text": "<p>Ashman phenomenon</p>"
        }
      ],
      "text": "<p>An individual experiences sudden death, and their ECG reveals ST segment elevation in leads V1-V3 along with right bundle branch block. What is the most probable diagnosis? (NEET PG 2015)</p>",
      "unique_key": "Q6110692",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934785,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Correct Answer: C. Brugada syndrome</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Brugada syndrome is characterized by a distinctive ECG pattern showing ST segment elevation in right precordial leads (V1-V3) with a right bundle branch block (RBBB) appearance. This genetic disorder affects cardiac sodium channels and predisposes patients to ventricular arrhythmias and sudden cardiac death, especially during sleep or rest. The ECG abnormalities can wax and wane over time and may become more pronounced during acute illness and fever. The pattern includes a coved ST elevation followed by a negative T wave in the right precordial leads.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option</strong> <strong>A.</strong> <strong>Hypertrophic obstructive cardiomyopathy (HOCM):</strong> Though HOCM is a cause of sudden cardiac death, its ECG findings typically include left ventricular hypertrophy, deep Q waves in lateral and inferior leads, and ST-T wave abnormalities. It does not produce the characteristic ST elevation in V1-V3 with RBBB pattern seen in Brugada syndrome.</p><p>&nbsp;</p><p><strong>Option</strong> <strong>B.</strong> <strong>Aortic valve stenosis:</strong> While aortic stenosis can cause sudden death, its ECG findings typically include left ventricular hypertrophy and ST-T wave abnormalities in lateral leads. It doesn't cause the specific pattern of ST elevation in V1-V3 with RBBB seen in this case.</p><p>&nbsp;</p><p><strong>Option</strong> <strong>D. Ashman phenomenon:</strong> This is a conduction abnormality characterized by aberrant ventricular conduction (typically RBBB morphology) following a short-long R-R interval sequence. It is not associated with ST elevation in V1-V3 and is not a cause of sudden cardiac death.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Brugada syndrome presents with a distinctive ECG pattern of ST elevation in right precordial leads (V1-V3) with RBBB appearance and is an important cause of sudden cardiac death in structurally normal hearts, especially in young adults.</p>",
      "correct_choice_id": 186757,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50937,
      "choices": [
        {
          "id": 203287,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenylyl cyclase</span></p>"
        },
        {
          "id": 203288,
          "text": "<p><span style=\"font-size:12.0pt;\">Guanylyl cyclase</span></p>"
        },
        {
          "id": 203289,
          "text": "<p><span style=\"font-size:12.0pt;\">Phospholipase C</span></p>"
        },
        {
          "id": 203290,
          "text": "<p><span style=\"font-size:12.0pt;\">Phospholipase a</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which enzyme catalyzes the conversion of a compound into IP3 and DAG? (NEET PG 2016)</span></p>",
      "unique_key": "Q5774106",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934786,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Correct Answer: C. Phospholipase C</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Phospholipase C (PLC) is the enzyme that catalyzes the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) in the cell membrane to generate two important second messengers: inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). This reaction occurs when a ligand binds to a receptor (either G-protein coupled or tyrosine kinase receptor) that activates PLC. Subsequently, IP3 diffuses to the endoplasmic reticulum where it triggers calcium release, while DAG remains in the membrane to activate protein kinase C.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;a. Adenylyl cyclase</strong>: This enzyme catalyzes the conversion of ATP to cyclic AMP (cAMP), not IP3 and DAG. It's activated by stimulatory G-proteins (Gs) after receptor binding and generates cAMP as a second messenger.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;b. Guanylyl cyclase</strong>: This enzyme catalyzes the formation of cyclic GMP (cGMP) from GTP. It exists in both membrane-bound and soluble forms, with the latter activated by nitric oxide. It does not produce IP3 or DAG.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;d. Phospholipase A</strong>: This enzyme cleaves fatty acids from the sn-2 position of membrane phospholipids, generating arachidonic acid and lysophospholipids. It's involved in the production of eicosanoids but not IP3 or DAG.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The phosphoinositide signaling pathway involves phospholipase C-mediated hydrolysis of PIP2 to generate two distinct second messengers (IP3 and DAG) that work in tandem to increase intracellular calcium and activate protein kinase C, coordinating comprehensive cellular responses.</span></p>",
      "correct_choice_id": 203289,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47509,
      "choices": [
        {
          "id": 189647,
          "text": "<p><span style=\"font-size:12.0pt;\">Asthma</span></p>"
        },
        {
          "id": 189648,
          "text": "<p><span style=\"font-size:12.0pt;\">Peripheral eosinophilia</span></p>"
        },
        {
          "id": 189649,
          "text": "<p><span style=\"font-size:12.0pt;\">Vasculitis of multiple organ systems</span></p>"
        },
        {
          "id": 189650,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravascular granulomas</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements about Churg-Strauss Syndrome is not true?(NEET PG 2017)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></p>",
      "unique_key": "Q4605705",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934787,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. D) Intravascular granulomas</strong></p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Churg-Strauss Syndrome, now known as Eosinophilic Granulomatosis with Polyangiitis (EGPA), is characterized by <strong>extravascular granulomas</strong>, not intravascular granulomas. EGPA features granulomatous reactions that are present in tissues or even within the walls of vessels, but they are not typically found inside the vessel lumen (intravascular).</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Asthma:&nbsp;</strong>Asthma is a characteristic feature of EGPA. Pulmonary findings dominate the clinical picture, with severe asthmatic attacks being a hallmark presentation. Asthma typically occurs early in the disease course and is present in virtually all patients with this condition.</p><p>&nbsp;</p><p><strong>Option B. Peripheral eosinophilia:&nbsp;</strong>&nbsp;Peripheral eosinophilia is a hallmark laboratory finding in EGPA. The characteristic finding is striking eosinophilia, which reaches levels &gt;1000 cells/Î¼L in &gt;80% of patients. This is a key diagnostic criterion for the condition.</p><p>&nbsp;</p><p><strong>Option C. Vasculitis of multiple organ systems:&nbsp;</strong>EGPA involves vasculitis affecting multiple organ systems. The necrotizing vasculitis involves small- and medium-sized muscular arteries, capillaries, veins, and venules. Common sites of involvement include lungs, skin, cardiovascular system, kidneys, peripheral nervous system, and gastrointestinal tract.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss) is characterized by the triad of asthma, peripheral eosinophilia, and vasculitis, with <strong>extravascular</strong> granulomatous inflammation being a key histopathologic finding. These granulomas are present in tissues or vessel walls, not within the vessel lumen.</p>",
      "correct_choice_id": 189650,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11414,
      "choices": [
        {
          "id": 45622,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Serum Potassium</span></p>"
        },
        {
          "id": 45623,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Serum Magnesium</span></p>"
        },
        {
          "id": 45624,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Serum Sodium</span></p>"
        },
        {
          "id": 45625,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Serum Calcium</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">A 36-year-old male came with complaints of ascending weakness in both lower limb and upper body. There was no history of trauma. Which of the following is the next investigation? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q7137315",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934788,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Serum Potassium</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Disturbance in serum potassium levels (hypokalemia or hyperkalemia) present with ascending muscle weakness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Serum Magnesium:</strong> Incorrect for this scenario as disturbances in magnesium typically cause tetany (muscle spasms) when low and generalized weakness when high, but are less directly linked to the type of ascending muscle weakness described.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Serum Sodium:</strong> Incorrect because changes in serum sodium levels generally affect neurological function but do not typically cause muscular weakness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Serum Calcium:</strong> Incorrect as calcium imbalances would more likely cause tetany (from hypocalcemia) or symptoms like fatigue, depression, and cardiac arrhythmias (from hypercalcemia), rather than ascending muscle weakness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The disturbances in serum potassium levels can manifest as muscle weakness, making it a vital test in cases of unexplained, ascending muscle weakness without trauma.</span></p>",
      "correct_choice_id": 45622,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11215,
      "choices": [
        {
          "id": 44826,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum ceruloplasmin levels</span></span></span></span></p>"
        },
        {
          "id": 44827,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum copper levels</span></span></span></span></p>"
        },
        {
          "id": 44828,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enzyme assay</span></span></span></span></p>"
        },
        {
          "id": 44829,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Karyotyping</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A child presents with hepatitis and progressive neurological degeneration. A picture of his eye has been provided below. Among the following options, what would be the initial step regarding the investigations done for this child&#39;s diagnosis? (NEET PG 2018)</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/01/screenshot-2024-10-01-113817.png\" style=\"height:203px; width:300px\" /></p>",
      "unique_key": "Q6384204",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934789,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Serum ceruloplasmin levels </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image of the eye, showing a possible Kayser-Fleischer ring, along with symptoms of hepatitis and progressive neurological degeneration, strongly suggests Wilson disease. Wilson disease is a genetic disorder affecting copper metabolism. The initial screening test in suspected cases is the measurement of serum ceruloplasmin levels, as ceruloplasmin is the primary copper-carrying protein in the blood, and levels are typically reduced in Wilson disease.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/nm13.jpg\" style=\"height:646px; width:700px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Serum copper levels:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This test is used to further support the diagnosis after abnormalities in ceruloplasmin levels are noted. Total serum copper is typically low in Wilson disease, but free copper is elevated due to the low ceruloplasmin levels.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Enzyme assay:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Not relevant for Wilson disease, which involves a defect in copper transport rather than an enzyme deficiency.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Karyotyping:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Also not relevant, as Wilson disease is related to mutations in the ATP7B gene, not chromosomal abnormalities.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a child presenting with hepatitis and neurological symptoms, the presence of a Kayser-Fleischer ring strongly suggests Wilson disease. The first diagnostic step is to measure serum ceruloplasmin levels.</span></span></span></span></p>",
      "correct_choice_id": 44826,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47533,
      "choices": [
        {
          "id": 189743,
          "text": "<p><span style=\"font-size:12.0pt;\">Amitriptyline</span></p>"
        },
        {
          "id": 189744,
          "text": "<p><span style=\"font-size:12.0pt;\">Gabapentin</span></p>"
        },
        {
          "id": 189745,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbamazepine</span></p>"
        },
        {
          "id": 189746,
          "text": "<p><span style=\"font-size:12.0pt;\">Ibuprofen</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is least useful in the management of a patient with Thalamic Dejerine syndrome?</span></p>",
      "unique_key": "Q2070538",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934790,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Ibuprofen</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thalamic Dejerine syndrome, also known as Dejerine-Roussy syndrome, is characterized by chronic, intense pain on the contralateral side of the body following a thalamic stroke. The pain is often resistant to typical analgesics and requires specific management with medications that target neuropathic pain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Medications useful in managing Thalamic Dejerine syndrome include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Amitriptyline:&nbsp;</strong>A tricyclic antidepressant effective in treating neuropathic pain.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Gabapentin:&nbsp;</strong>An anticonvulsant used to manage neuropathic pain.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Carbamazepine:&nbsp;</strong>An anticonvulsant also used for neuropathic pain management.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ibuprofen</strong>, a nonsteroidal anti-inflammatory drug (NSAID), is not effective for neuropathic pain and therefore is the least useful in managing Thalamic Dejerine syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A, B &amp; C</strong> are effective for neuropathic pain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ibuprofen is least useful for managing Thalamic Dejerine syndrome, which requires medications that target neuropathic pain.</span></p>",
      "correct_choice_id": 189746,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24777,
      "choices": [
        {
          "id": 99069,
          "text": "<p><span style=\"font-size:11.0pt;\">Centromeric</span></p>"
        },
        {
          "id": 99070,
          "text": "<p><span style=\"font-size:11.0pt;\">Homogenous</span></p>"
        },
        {
          "id": 99071,
          "text": "<p><span style=\"font-size:11.0pt;\">Speckled</span></p>"
        },
        {
          "id": 99072,
          "text": "<p><span style=\"font-size:11.0pt;\">Nucleolar</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Identify the type of ANA staining pattern shown in the image below? (INICET MAY 2023)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-152907.png\" alt=\"\" width=\"300\" height=\"294\"></span></p>",
      "unique_key": "Q9858959",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934791,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A)&nbsp;Centromeric</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The centromeric pattern is characterized by distinct dots in the nucleus, corresponding to centromeres during cell division. This pattern is associated with <strong>anti-centromere antibodies (ACA)</strong>, commonly seen in limited cutaneous scleroderma (CREST syndrome). ACA antibody&nbsp;is&nbsp; correlate with pulmonary hypertension seen in patients with limited disease.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Homogenous:</strong> Diffuse staining of the nucleus, seen with anti-ds DNA antibodies or anti-histone antibodies.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Speckled</strong>: Numerous fine or coarse speckles, a kind of quite nonspecific, associated with various antibodies such as anti-SEL70, anti-JOAN, and anti-SMITH antibodies, etc</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Nucleolar</strong>: Prominent nucleolar staining, quite nonspecific, seen with Anti-PM-Scl antibody, an overlap antibody.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Centromeric pattern in ANA staining is associated with anti-centromere antibodies and limited scleroderma.</span></p>",
      "correct_choice_id": 99069,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11634,
      "choices": [
        {
          "id": 46502,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hyperphosphatemia</span></span></span></p>"
        },
        {
          "id": 46503,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hyperuricemia </span></span></span></p>"
        },
        {
          "id": 46504,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypercalcemia </span></span></span></p>"
        },
        {
          "id": 46505,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hyperkalemia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following is not seen in tumor lysis syndrome ? (AIIMS NOV 2017)</span></span></span></p>",
      "unique_key": "Q9937810",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934792,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Hypercalcemia&nbsp; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tumor lysis syndrome occurs due to destruction of large no of rapidly proliferating neoplstic cells. It is characterised by Hyperuricemia, hyperkalemia , hyperphosphasphatemia, hypocalcemia, acidosis, acute renal failure. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It mainly occurs after initiation of chemotherapy and is diagnosed by Cairo bishop criteria (includes both lab and clinical features)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Management includes - allopurinol , rasburicase along with aggressive hydration .</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Hyperphosphatemia</span></strong><span style=\"font-size:12.0pt\">: Typically occurs as phosphate is released from lysed tumor cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Hyperuricemia</span></strong><span style=\"font-size:12.0pt\">: Results from the metabolism of nucleic acids from destroyed cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hyperkalemia</span></strong><span style=\"font-size:12.0pt\">: Occurs due to the release of potassium from the intracellular to the extracellular space.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In tumor lysis syndrome, the rapid breakdown of tumor cells leads to <strong>hypocalcemia</strong>, not hypercalcemia, making this the key distinguishing feature in identifying the condition. Management strategies like hydration, use of allopurinol, or rasburicase are critical in preventing renal failure and other serious complications.</span></span></span></p>",
      "correct_choice_id": 46504,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11755,
      "choices": [
        {
          "id": 46986,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal disorders</span></span></span></span></p>"
        },
        {
          "id": 46987,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lactic acidosis</span></span></span></span></p>"
        },
        {
          "id": 46988,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diabetic ketoacidosis</span></span></span></span></p>"
        },
        {
          "id": 46989,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Salicylate poisoning</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High anion gap acidosis with low bicarbonate levels is seen in all the following conditions except: (INICET NOV 2020)</span></span></p>",
      "unique_key": "Q5808368",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934793,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal Disorders</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High anion gap metabolic acidosis (HAGMA) is characterized by the accumulation of acids in the body, which are not accompanied by an increase in other measured anions, thus increasing the anion gap. This condition typically involves a decrease in bicarbonate as the body tries to buffer the excess hydrogen ions.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Lactic Acidosis</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This condition occurs when lactate levels increase in the bloodstream during tissue hypoxia, commonly seen in shock or severe dehydration, and results in HAGMA.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Diabetic Ketoacidosis</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In DKA, the body produces high levels of blood acids called ketones, which lead to HAGMA.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Salicylate Poisoning</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In salicylate toxicity, especially at higher doses, metabolic acidosis occurs due to uncoupling of oxidative phosphorylation, leading to HAGMA. Initially, salicylate stimulates the respiratory center causing a respiratory alkalosis, which can be followed by metabolic acidosis at higher doses.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal disorders typically cause non-anion gap metabolic acidosis (NAGMA) due to an inability to excrete acid or conserve bicarbonate, rather than high anion gap acidosis seen in conditions like lactic acidosis, diabetic ketoacidosis, and salicylate poisoning.</span></span></span></span></p>",
      "correct_choice_id": 46986,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11257,
      "choices": [
        {
          "id": 44994,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Burns</span></span></p>"
        },
        {
          "id": 44995,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stress</span></span></p>"
        },
        {
          "id": 44996,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Head injury</span></span></p>"
        },
        {
          "id": 44997,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cell necrosis</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cushing&#39;s ulcers are seen in? (NEET PG 2019)</span></span></p>",
      "unique_key": "Q5869473",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934794,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Head injury</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cushing&#39;s ulcers are specifically associated with head injuries or conditions that lead to increased intracranial pressure (ICP). The mechanism involves vagal nerve stimulation due to the increased ICP, which in turn causes an overproduction of gastric acid leading to the development of ulcers. This is distinct from other types of stress-related gastric ulcers.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Burns:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This type of ulcer is known as Curling&#39;s ulcer, which occurs in response to severe burns and is related to the physiological stress and possible hypovolemia resulting from the burn injury, not the brain injury-related mechanism of Cushing&#39;s ulcers.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Stress:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While stress can indeed lead to gastric ulcers, the specific term &quot;Cushing&#39;s ulcers&quot; is not used in this context. General stress-related ulcers do not typically involve the mechanism of vagal stimulation due to increased ICP.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Cell necrosis:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a general process that can occur in many pathological conditions but does not specifically relate to the formation of Cushing&#39;s ulcers.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cushing&#39;s ulcers are a specific type of peptic ulcer that occurs due to increased intracranial pressure resulting from head injuries. Recognizing this condition is important for managing patients with significant neurological trauma to prevent and treat these potentially serious gastrointestinal complications.</span></span></p>",
      "correct_choice_id": 44996,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11620,
      "choices": [
        {
          "id": 46446,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcified valve</span></p>"
        },
        {
          "id": 46447,
          "text": "<p><span style=\"font-size:12.0pt;\">Aortic regurgitation</span></p>"
        },
        {
          "id": 46448,
          "text": "<p><span style=\"font-size:12.0pt;\">First degree heart block</span></p>"
        },
        {
          "id": 46449,
          "text": "<p><span style=\"font-size:12.0pt;\">Mild mitral stenosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The absence of loud S1 in mitral stenosis would indicate all of the following, except:</span><span style=\"font-size:11pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p>",
      "unique_key": "Q9445488",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934795,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D) Mild mitral stenosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The first heart sound (S1) is produced by the closure of the mitral and tricuspid valves at the beginning of systole. In mitral stenosis, the loudness of S1 can vary depending on several factors. A loud S1 is typically associated with the early stages of mitral stenosis when the valve leaflets are still relatively mobile. However, in certain conditions, S1 can become softer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In mild mitral stenosis without significant calcification usually results in a loud S1. This is because the mitral valve leaflets are still relatively mobile and can close forcefully. Therefore, mild mitral stenosis is the correct exception in this context, as it does not typically cause a soft S1.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Calcified valve:</strong> When the mitral valve becomes calcified, it loses its mobility. This results in a softer S1 because the valve leaflets are not able to close rapidly or forcefully.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Aortic regurgitation:</strong> Aortic regurgitation can lead to an increased preload in the left ventricle, which can in turn affect the closure of the mitral valve, making S1 softer. Additionally, mitral regurgitation, which often coexists with mitral stenosis, can also soften S1.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. First degree heart block:</strong> In first degree AV block, there is a prolonged PR interval. This delayed conduction can lead to a less forceful closure of the mitral valve, resulting in a softer S1.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In mitral stenosis, a loud S1 is typically seen in the early stages with mobile valves, while a soft S1 can indicate valve calcification, aortic regurgitation, or first degree heart block. Mild mitral stenosis without calcification usually results in a loud S1</span></p>",
      "correct_choice_id": 46449,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16179,
      "choices": [
        {
          "id": 64676,
          "text": "<p><span style=\"font-size:12.0pt;\">Small-cell lung cancer</span></p>"
        },
        {
          "id": 64677,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenal tumor</span></p>"
        },
        {
          "id": 64678,
          "text": "<p><span style=\"font-size:12.0pt;\">Ectopic ACTH syndrome</span></p>"
        },
        {
          "id": 64679,
          "text": "<p><span style=\"font-size:12.0pt;\">Pituitary microadenoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The most common cause of Cushing's disease in a 60-year-old male is: (FMGE JAN 2023)</span></p>",
      "unique_key": "Q2079449",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934796,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;<strong>D) Pituitary microadenoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Cushing's disease is specifically caused by a pituitary adenoma that secretes excess adrenocorticotropic hormone (ACTH). This excess ACTH stimulates the adrenal glands to produce more cortisol, leading to the symptoms of Cushing's syndrome. In the context of Cushing's disease, the term always refers to a pituitary origin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Cushing's syndrome, on the other hand, can have various causes:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Exogenous Cushing's syndrome:</strong> Due to external sources of cortisol, such as prolonged use of glucocorticoid medications.</span></li><li><span style=\"font-size:12pt;\"><strong>Endogenous Cushing's syndrome:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12pt;\">subdivided into â&nbsp;</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">ACTH-dependent - High ACTH levels stimulate cortisol production, associated with symptoms like hyperpigmentation.</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12pt;\">(e.g.</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12pt;\">pituitary adenoma/ cushingâs disease, ectopic ACTH secretion)</span></li><li><span style=\"font-size:12pt;\">ACTH-independent - Low or normal ACTH levels, with cortisol overproduction directly from the adrenal glands (e.g., adrenal adenoma, adrenal carcinoma).</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Among the endogenous causes, pituitary adenomas (Cushing's disease) are the most common, responsible for about 60-65% of cases. Ectopic ACTH secretion accounts for about 20-25% of cases, and adrenal tumors are responsible for 5-10% of cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Small-cell lung cancer:</strong> Can cause ectopic ACTH syndrome but is not the most common cause of Cushing's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Adrenal tumor:</strong> Can cause Cushing's syndrome but is less common compared to pituitary adenomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Ectopic ACTH syndrome:</strong> Can be caused by various tumors, including small-cell lung cancer, but is not as common as pituitary adenomas in causing Cushing's disease.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Pituitary microadenoma is the most common cause of Cushing's disease, which is characterized by excess ACTH production from the pituitary gland.</span></p>",
      "correct_choice_id": 64679,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11474,
      "choices": [
        {
          "id": 45862,
          "text": "<p><span style=\"font-size:12.0pt;\">Risk of thrombosis strongly correlates with the degree of thrombocytosis</span></p>"
        },
        {
          "id": 45863,
          "text": "<p><span style=\"font-size:12.0pt;\">It is protective against H. pylori infection</span></p>"
        },
        {
          "id": 45864,
          "text": "<p><span style=\"font-size:12.0pt;\">Generalized pruritus is a consequence of mast cell activation by JAK 2 mutation</span></p>"
        },
        {
          "id": 45865,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute myeloid leukemia is the most common cause of mortality</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements about polycythemia vera is true? (AIIMS MAY 2019)</span></p>",
      "unique_key": "Q1926209",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934797,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Generalized pruritus is a consequence of mast cell activation by JAK 2 mutation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Polycythemia vera (PV) is a myeloproliferative neoplasm characterized by the overproduction of red blood cells. It is commonly associated with a mutation in the JAK2 gene, which can also affect other cell types, including mast cells. Activation of these cells can lead to the release of histamine, which is thought to contribute to the itching or pruritus often experienced by patients, particularly after warm baths or showers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Myeloproliferative neoplasms include PCV, CML, and PMF.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Risk of thrombosis strongly correlates with the degree of thrombocytosis:&nbsp;</strong>Incorrect. Although thrombocytosis is present in polycythemia vera, thrombosis risk correlates more significantly with leukocytosis and the presence of JAK2 mutation rather than solely with thrombocytosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. It is protective against H. pylori infection:&nbsp;</strong>Incorrect. There is no evidence to suggest that polycythemia vera provides protection against H. pylori infection. Patients with PV actually may have an increased risk of gastrointestinal issues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Acute myeloid leukemia is the most common cause of mortality:&nbsp;</strong>Incorrect. While patients with polycythemia vera do have an increased risk of transformation to acute myeloid leukemia (AML), the most common cause of mortality in these patients is thrombotic events such as heart attack or stroke.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Generalized pruritus in polycythemia vera, exacerbated by warmth or bathing, is a well-known symptom related to mast cell activation due to the JAK2 mutation. This mutation is a hallmark of the disease and leads to several systemic effects, including increased histamine release, which contributes to pruritus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">All MPN can develop AML, Myelofibrosis in the course of the disease.</span></p>",
      "correct_choice_id": 45864,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54274,
      "choices": [
        {
          "id": 216565,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dapagliflozin</span></span></p>"
        },
        {
          "id": 216566,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glimepiride</span></span></p>"
        },
        {
          "id": 216567,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metformin</span></span></p>"
        },
        {
          "id": 216568,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sitagliptin</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 30-year-old patient with heart failure and poorly controlled type 2 diabetes (HbA1c of 7.8%) presents with progressive dyspnea. Which is the preferred antidiabetic drug?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q8718982",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934798,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Dapagliflozin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dapagliflozin is a sodium-glucose co-transporter-2 (SGLT2) inhibitor that has shown significant benefits in patients with heart failure, particularly heart failure with reduced ejection fraction (HFrEF). SGLT2 inhibitors, including dapagliflozin and empagliflozin, have been demonstrated to improve survival, reduce heart failure hospitalizations, and delay the progression of heart failure. These benefits make SGLT2 inhibitors the preferred choice for patients with both type 2 diabetes and heart failure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Four Pillars in the Management of HFrEF (Heart Failure with Reduced Ejection Fraction):</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">ARNIs and ACE Inhibitors/ARBs</span></strong><span style=\"font-size:12.0pt\">:</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ARNIs (e.g., Sacubitril/Valsartan) are preferred.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ACE Inhibitors/ARBs are also used.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Beta Blockers</span></strong><span style=\"font-size:12.0pt\">:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Metoprolol</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bisoprolol</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Carvedilol</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">MRAs (Mineralocorticoid Receptor Antagonists)</span></strong><span style=\"font-size:12.0pt\">:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Spironolactone</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Eplerenone</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">SGLT2 Inhibitors</span></strong><span style=\"font-size:12.0pt\">:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Empagliflozin</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dapagliflozin</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Glimepiride:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a sulfonylurea that primarily helps in lowering blood glucose by stimulating insulin secretion. It does not provide the cardiovascular benefits seen with SGLT2 inhibitors and can increase the risk of hypoglycemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Metformin:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> While metformin is a first-line therapy for type 2 diabetes and has some cardiovascular benefits, it is not specifically indicated for improving heart failure outcomes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Sitagliptin:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a dipeptidyl peptidase-4 (DPP-4) inhibitor used to manage blood glucose levels. It does not provide the same level of heart failure benefit as SGLT2 inhibitors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For patients with type 2 diabetes and heart failure, SGLT2 inhibitors like dapagliflozin are the preferred antidiabetic medications due to their proven benefits in reducing heart failure progression, hospitalizations, and mortality.</span></span></span></p>",
      "correct_choice_id": 216565,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11287,
      "choices": [
        {
          "id": 45114,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low</span></span></p>"
        },
        {
          "id": 45115,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High</span></span></p>"
        },
        {
          "id": 45116,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Moderate</span></span></p>"
        },
        {
          "id": 45117,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cannot comment without d-dimer values</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 53-year-old woman underwent hip replacement surgery. A week after the surgery, the patient developed swelling of the legs associated with pain on palpation. Her heart rate is 70 beats per min. There is no history of hemoptysis or significant weight loss. There is no previous history of pulmonary embolism. What is the risk of developing pulmonary embolism in the patient based on Well&#39;s score? (NEET PG 2020)</span></span></p>",
      "unique_key": "Q6917858",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934799,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. High </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Well&#39;s Score is a clinical tool used to estimate the probability of a pulmonary embolism (PE). The score is calculated based on various risk factors and clinical features. In this patient&#39;s case:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Modified wells criteria: 3 + 3 + 1.5 = 7.5 (&gt;4) suggestive of high risk.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/24/screenshot-2024-07-24-113426.jpg\" style=\"height:610px; width:981px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inference:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4: PE Likely </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&lt; 4: PE unlikely</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When assessing the risk of pulmonary embolism, especially in postoperative patients presenting with symptoms suggestive of DVT, it is essential to consider both the clinical presentation and the surgical history. The Wells score is a valuable tool in stratifying the risk and guiding further diagnostic testing and management. In this scenario, the patient falls into a high-risk category, indicating that further immediate investigation, typically with imaging like a CT pulmonary angiogram, is warranted.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - UpToDate/Wells score</span></span></strong></p>",
      "correct_choice_id": 45115,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47621,
      "choices": [
        {
          "id": 190095,
          "text": "<p><span style=\"font-size:12.0pt;\">Furosemide</span></p>"
        },
        {
          "id": 190096,
          "text": "<p><span style=\"font-size:12.0pt;\">Digoxin</span></p>"
        },
        {
          "id": 190097,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin</span></p>"
        },
        {
          "id": 190098,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Patient develops severe migratory joint pain after an attack of acute rheumatic fever. How will you manage this patient? (</span>FMGE Jan 2024)</p>",
      "unique_key": "Q9742790",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934800,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Aspirin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct answer is Aspirin. Acute rheumatic fever commonly presents with <strong>migratory polyarthritis</strong>, which is characterized by severe joint pain that moves from one joint to another.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The treatment of choice for this arthritis is nonsteroidal anti-inflammatory drugs (NSAIDs), with aspirin being the most effective and commonly used. Aspirin helps to reduce inflammation and pain associated with the arthritis of acute rheumatic fever.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Furosemide:&nbsp;</strong>This is a diuretic and is not used for the management of arthritis in acute rheumatic fever. It may be used in cases of heart failure associated with rheumatic carditis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Digoxin:&nbsp;</strong>This is a cardiac glycoside used in heart failure and atrial fibrillation. It is not used for managing arthritis in acute rheumatic fever.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Amiodarone:&nbsp;</strong>This is an antiarrhythmic medication and has no role in the management of arthritis in acute rheumatic fever.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The primary treatment for severe migratory joint pain (arthritis) in acute rheumatic fever is the use of NSAIDs, with aspirin being the drug of choice due to its effectiveness in reducing inflammation and pain.</span></p>",
      "correct_choice_id": 190097,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11458,
      "choices": [
        {
          "id": 45798,
          "text": "<p><span style=\"font-size:12.0pt;\">Brain infarct</span></p>"
        },
        {
          "id": 45799,
          "text": "<p><span style=\"font-size:12.0pt;\">Brainstem injury</span></p>"
        },
        {
          "id": 45800,
          "text": "<p><span style=\"font-size:12.0pt;\">Osmotic demyelination syndrome</span></p>"
        },
        {
          "id": 45801,
          "text": "<p><span style=\"font-size:12.0pt;\">Rare cause of hypernatremia</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 60-year gentleman was referred from outside hospital to AIIMS ER after he developed sudden onset quadriparesis. In hospital patient was treated with 3%NaCl, Oral tolvaptan. Initial metabolic panel revealed Na: 115 mEq/L, K: 2.8 mEq/L, Cl: 85 mEq/L with normal TSH, CBC, RFT, LFT.&nbsp; What is the most likely cause for this patient's condition?&nbsp; (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q7190663",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934801,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Osmotic demyelination syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Previously called central pontine myelinolysis. It occurs due to rapid correction of Chronic Hyponatremia (&gt;8 mg/dL).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Timing:&nbsp;</strong>2-6 days after rapid correction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Rx:</strong> Irreversible. Desmopressin clamp if overcorrection in q6h Na values.&nbsp;&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mechanism:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. In Hyponatremia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture53_qnfCv6M.jpg\" alt=\"\" width=\"500\" height=\"453\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. On sudden correction:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture54_956T8fI.jpg\" alt=\"\" width=\"500\" height=\"252\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Risk factors:</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12.0pt;\">Serum sodium â¤ 105 mEq/L</span></li><li><span style=\"font-size:12.0pt;\">Concurrent hypokalemia</span></li><li><span style=\"font-size:12.0pt;\">Chronic excess alcohol intake</span></li><li><span style=\"font-size:12.0pt;\">Acute or chronic hepatic disease</span></li><li><span style=\"font-size:12.0pt;\">Malnourishment</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Brain infarct:&nbsp;</strong>Not directly suggested by the rapid onset of symptoms following electrolyte correction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Brainstem injury:&nbsp;</strong>Could be considered but is less likely without trauma or vascular insult history.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Rare cause of hypernatremia:&nbsp;</strong>Not applicable as the condition involves the rapid correction of hyponatremia, not hypernatremia itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rapid correction of chronic hyponatremia should be avoided to prevent the severe neurological complications associated with osmotic demyelination syndrome. Control and monitoring of serum sodium levels are crucial during treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Electrolytes/Chap 53</strong></span></p>",
      "correct_choice_id": 45800,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11798,
      "choices": [
        {
          "id": 47158,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Right to left shunt</span></span></p>"
        },
        {
          "id": 47159,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ventilation/Perfusion mismatch</span></span></p>"
        },
        {
          "id": 47160,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypoventilation</span></span></p>"
        },
        {
          "id": 47161,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alveolar membrane damage</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient came with hypoxemia and a normal alveolar-arterial oxygen gradient. What can be the cause? (INICET NOV 2021)</span></span></span></p>",
      "unique_key": "Q8889770",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934802,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Hypoventilation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypoxemia with a normal alveolar-arterial (A-a) oxygen gradient typically points to specific causes where the alveolar oxygen (PAO2) and arterial oxygen (PaO2) levels remain proportionate. In this scenario, the primary causes are hypoventilation and situations involving low inspired oxygen tension (low FiO2).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Hypoventilation:</span></strong><span style=\"font-size:12.0pt\"> This condition leads to hypoxemia due to inadequate ventilation. When ventilation is insufficient, the amount of oxygen entering the alveoli drops, leading to a corresponding decrease in the amount of oxygen diffusing into the blood, resulting in hypoxemia. However, because the underlying issue is with ventilation and not with oxygen diffusion or blood flow, the A-a gradient remains normal.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Low FiO2 or Low Barometric Pressure:</span></strong><span style=\"font-size:12.0pt\"> This can occur in scenarios such as high altitude where the barometric pressure is low, leading to reduced oxygen availability in the air. However, these situations were not explicitly listed among the answer choices.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">According to the reference paragraph, other conditions like ventilation/perfusion (V/Q) mismatch, diffusion limitation, and alveolar membrane damage, cause an increased A-a gradient due to impaired oxygen transfer across the alveolar membrane or mismatched ventilation and perfusion in the lungs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Right to left shunt:</strong> This condition causes hypoxemia due to blood bypassing the lungs and not getting oxygenated. It leads to an increased A-a gradient because the oxygen content of the arterial blood is significantly lower compared to the alveolar oxygen level.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Ventilation/Perfusion mismatch:</strong> This condition results from areas of the lung receiving oxygen but not perfused with blood or areas perfused with blood but not receiving oxygen. It causes an increased A-a gradient due to ineffective oxygen transfer to the blood.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Alveolar membrane damage:</strong> This results in impaired oxygen diffusion across the alveolar-capillary membrane, leading to an increased A-a gradient as oxygen transfer from alveoli to blood is hindered.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypoventilation is a primary cause of hypoxemia with a normal alveolar-arterial oxygen gradient.</span></span></span></p>",
      "correct_choice_id": 47160,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 52808,
      "choices": [
        {
          "id": 210721,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute interstitial nephritis</span></span></span></p>"
        },
        {
          "id": 210722,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Poststreptococcal glomerulonephritis</span></span></span></p>"
        },
        {
          "id": 210723,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lupus nephritis</span></span></span></p>"
        },
        {
          "id": 210724,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IgA nephropathy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A woman presents to you with fever, arthralgia, ulcers, fatigue for the past six months, and new-onset hematuria. Urine examination reveals RBC casts and proteinuria. What is the likely diagnosis? (NEET PG 2023)</span></span></span></p>",
      "unique_key": "Q3984765",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934803,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\">C. Lupus nephritis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lupus nephritis is a common complication of systemic lupus erythematosus (SLE), an autoimmune disease that can affect multiple organ systems. The patient&#39;s symptoms of fever, arthralgia, ulcers, and fatigue, combined with new-onset hematuria and findings of RBC casts and proteinuria in the urine, are indicative of systemic involvement typical of lupus nephritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lupus nephritis is characterized by inflammation of the kidneys, often leading to hematuria, proteinuria, and renal impairment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Next Step -</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Conducting an ANA (antinuclear antibody) test.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Performing an anti-dsDNA (anti-double stranded DNA) test, which is noted as being very specific and correlates with lupus nephritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A. Acute interstitial nephritis:</span></strong><span style=\"font-size:12.0pt\"> This condition typically presents with WBC casts rather than RBC casts in the urine and is not usually associated with systemic symptoms like fever, arthralgia, or ulcers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Poststreptococcal glomerulonephritis (PSGN):</span></strong><span style=\"font-size:12.0pt\"> While PSGN can cause RBC casts and proteinuria, it is generally a renal-limited condition and does not present with systemic symptoms like fever, arthralgia, and ulcers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. IgA nephropathy:</span></strong><span style=\"font-size:12.0pt\"> IgA nephropathy is also a renal-limited condition and typically does not present with systemic symptoms. It is characterized by recurrent episodes of gross hematuria, usually following upper respiratory infections.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lupus nephritis should be suspected in patients with systemic lupus erythematosus who present with renal symptoms such as hematuria and proteinuria, especially when accompanied by systemic symptoms like fever, arthralgia, ulcers, and fatigue. Further testing, including ANA and anti-dsDNA antibodies, is warranted to confirm the diagnosis.</span></span></p>",
      "correct_choice_id": 210723,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11697,
      "choices": [
        {
          "id": 46754,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PSVT </span></span></span></span></p>"
        },
        {
          "id": 46755,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ventricular bigeminy</span></span></span></span></p>"
        },
        {
          "id": 46756,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">P pulmonale</span></span></span></span></p>"
        },
        {
          "id": 46757,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Re-entrant atrial fibrillation</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given ECG depicts which of the following conditions:&nbsp; (AIIMS NOV 2018)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm112.jpg\" style=\"height:357px; width:700px\" /></p>",
      "unique_key": "Q5885480",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934804,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Ventricular bigeminy </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Premature ventricular complex (PVCs)- Have following features </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Broad QRS complex (&gt;120ms) with abnormal morphology</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Premature- i.e., occurs earlier than would be expected for the next sinus impulse</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Discordant ST segment and T wave changes.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Usually followed by a full compensatory pause</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PVCs often occur in repeating pattern: bigeminy, trigeminy, quadrigeminy </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Couplet: 2 consecutive PVCs is known as couplet</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Triplet: 3 consecutive PVCs is known as triplet</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. PSVT (Paroxysmal Supraventricular Tachycardia):&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition would show a fast, regular heart rate with narrow QRS complexes; not observed here.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. P pulmonale:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This involves peaked P waves seen in leads II, III, and aVF, typically due to right atrial enlargement; not evident in this ECG.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Re-entrant atrial fibrillation:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Would show an irregularly irregular rhythm without consistent P waves; this is not present in the ECG provided.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ventricular bigeminy is identified by the presence of alternating normal sinus beats and PVCs, each PVC typically followed by a compensatory pause, creating a repeating pattern of one normal beat followed by one abnormal beat.</span></span></span></span></p>",
      "correct_choice_id": 46755,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55370,
      "choices": [
        {
          "id": 220941,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Phenytoin</span></span></p>"
        },
        {
          "id": 220942,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Hydrocarbon</span></span></p>"
        },
        {
          "id": 220943,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Unknown poisoning within 1 hour</span></span></p>"
        },
        {
          "id": 220944,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Paracetamol</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Gastric lavage is contraindicated in which of the following poisoning? (FMGE JULY 2024)</span></span></p>",
      "unique_key": "Q8910984",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934875,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B) Hydrocarbon</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Gastric lavage is contraindicated in two types of poisoning: Hydrocarbon and corrosive poisoning.&nbsp; </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Hydrocarbons are substances such as gasoline, kerosene, or certain cleaning agents, which are highly volatile and can easily be aspirated into the lungs during the procedure. This can lead to severe chemical pneumonitis and other respiratory complications, making the risks of gastric lavage significantly higher than any potential benefits.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Phenytoin: </strong>Gastric lavage is not typically contraindicated in phenytoin poisoning. While it is not the first line of treatment, it can be considered if the patient presents soon after ingestion.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Unknown poisoning within 1 hour: </strong>For unknown poisoning, especially if within 1 hour of ingestion, gastric lavage might still be considered, although it is generally falling out of favor due to risks and effectiveness. However, it is not specifically contraindicated.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Paracetamol: </strong>Gastric lavage is not contraindicated in paracetamol (acetaminophen) poisoning. The mainstay of treatment for paracetamol poisoning is N-acetylcysteine (NAC) administration, but if the patient presents early, gastric lavage can be considered.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Gastric lavage is contraindicated in hydrocarbon poisoning due to the high risk of aspiration and subsequent chemical pneumonitis. In any case of poisoning, the potential risks and benefits of gastric lavage must be carefully considered. </span></span></p>",
      "correct_choice_id": 220942,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11366,
      "choices": [
        {
          "id": 45430,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Megacolon</span></span></span></p>"
        },
        {
          "id": 45431,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Parathyroid adenoma</span></span></span></p>"
        },
        {
          "id": 45432,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mucosal neuroma</span></span></span></p>"
        },
        {
          "id": 45433,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Marfanoid habitus</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following is not seen in MEN 2B syndrome? (Neet pg 2022)</span></span></span></p>",
      "unique_key": "Q5594578",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934876,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Parathyroid adenoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Parathyroid adenomas</span></strong><span style=\"font-size:12.0pt\"> are not seen in MEN 2B. Parathyroid adenomas are typically associated with MEN 1 and MEN 2A syndromes, where hyperparathyroidism is a common feature due to the involvement of the parathyroid glands.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Multiple Endocrine Neoplasia type 2B (MEN 2B) is a genetic syndrome characterized by specific clinical features. It is also known as the &quot;<strong>Triple M syndrome</strong>&quot; because it typically presents with the following:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Mucosal Neuromas:</span></strong><span style=\"font-size:12.0pt\"> These are benign growths on the mucous membranes and are a hallmark of MEN 2B.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Marfanoid Habitus:</span></strong><span style=\"font-size:12.0pt\"> This refers to a body habitus resembling Marfan syndrome, with features like long limbs, a tall, slender build, and hyperflexible joints.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Medullary Thyroid Carcinoma (MTC):</span></strong><span style=\"font-size:12.0pt\"> This is a type of thyroid cancer commonly associated with MEN 2B.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Other features that can be seen in MEN 2B include pheochromocytomas (tumors of the adrenal glands) and ganglioneuromas (tumors of the nerve cells).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Megacolon:&nbsp;</strong>Megacolon can be associated with MEN 2B due to the presence of ganglioneuromatosis affecting the gastrointestinal tract.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Mucosal Neuroma:&nbsp;</strong>As mentioned, mucosal neuromas are a classic feature of MEN 2B and one of the reasons it is called &quot;triple M syndrome.&quot;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Marfanoid Habitus:&nbsp;</strong>This characteristic physical appearance is commonly seen in MEN 2B patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MEN 2B syndrome, also known as &quot;triple M syndrome,&quot; is characterized by mucosal neuromas, marfanoid habitus, and medullary thyroid carcinoma, but does not involve parathyroid adenomas.</span></span></span></p>",
      "correct_choice_id": 45431,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 66109,
      "choices": [
        {
          "id": 263581,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic Granulomatous Disease</span></p>"
        },
        {
          "id": 263582,
          "text": "<p><span style=\"font-size:12.0pt;\">Severe Combined Immunodeficiency</span></p>"
        },
        {
          "id": 263583,
          "text": "<p><span style=\"font-size:12.0pt;\">Leukocyte Adhesion Defect (LAD)</span></p>"
        },
        {
          "id": 263584,
          "text": "<p><span style=\"font-size:12.0pt;\">Chediak-Higashi Syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 7-year-old boy presents with recurrent infections, including delayed separation of the umbilical cord at birth, recurrent skin and mucosal infections, and poor wound healing. Laboratory findings show an absence of CD18 on leukocyte flow cytometry. What is the primary suspicion based on these findings? <i>(Twisted PYQ)</i></span></p>",
      "unique_key": "Q2834788",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934877,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Leukocyte Adhesion Defect (LAD)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Leukocyte Adhesion Defect (LAD)</strong> is a rare immunodeficiency characterized by defects in leukocyte migration and adhesion, due to mutations affecting integrins such as CD18 (LAD type&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1) Clinical features include:</span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Delayed separation of the umbilical cord:</strong> A hallmark feature.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Recurrent skin and mucosal infections:</strong> Often without pus formation due to impaired leukocyte migration.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Poor wound healing:</strong> Caused by defective leukocyte adhesion and migration to sites of infection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Diagnosis is confirmed by flow cytometry showing the absence or reduced expression of CD18 on leukocytes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Chronic Granulomatous Disease:</strong> Incorrect because CGD involves defects in the NADPH oxidase enzyme, leading to impaired oxidative killing of pathogens, which is detected by an abnormal DHR or NBT test. It presents with recurrent abscesses and lymphadenitis, not delayed cord separation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Severe Combined Immunodeficiency:</strong> Incorrect because SCID presents with profound defects in both T- and B-lymphocyte immunity, leading to severe infections early in life, and does not involve delayed cord separation or lack of pus formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Chediak-Higashi Syndrome:</strong> Incorrect because Chediak-Higashi syndrome involves defects in lysosomal trafficking, leading to giant granules in leukocytes and recurrent infections, as well as features like partial albinism and neurologic symptoms, which are not seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Leukocyte Adhesion Defect (LAD) is characterized by delayed umbilical cord separation, recurrent infections without pus formation, and poor wound healing. The diagnosis is confirmed by the absence or reduced expression of CD18 on leukocytes in flow cytometry. Early recognition is crucial to prevent severe complications</span></p>",
      "correct_choice_id": 263583,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50969,
      "choices": [
        {
          "id": 203417,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malignancy&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203418,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary hyperparathyroidism&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203419,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin D toxicity&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203420,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial hypocalciuric hypercalcemia&nbsp;</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common cause of hypercalcemia in hospitalized patients is (</span></span>INICET Nov 2023</p>",
      "unique_key": "Q4274848",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934878,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Malignancy</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: &nbsp;</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In hospitalized patients, the most common cause of hypercalcemia is malignancy. Malignancy-associated hypercalcemia often results from the secretion of parathyroid hormone-related peptide (PTHrP) by cancer cells, which mimics the effects of parathyroid hormone, leading to increased calcium levels. This is frequently seen in cancers such as breast cancer, lung cancer, and multiple myeloma.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Primary hyperparathyroidism:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is the most common cause of hypercalcemia in outpatients but not in hospitalized patients. It is characterized by elevated levels of parathyroid hormone (PTH) due to parathyroid gland hyperplasia, adenoma, or carcinoma.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Vitamin D toxicity:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypercalcemia can occur due to excessive intake of vitamin D, leading to increased intestinal absorption of calcium. However, it is not the most common cause in hospitalized patients.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Familial hypocalciuric hypercalcemia:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a rare genetic condition characterized by benign hypercalcemia with low urinary calcium excretion. It mimics primary hyperparathyroidism but is less common and typically not seen as the most frequent cause of hypercalcemia in hospitalized patients.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malignancy is the most common cause of hypercalcemia in hospitalized patients, often due to the secretion of PTHrP by cancer cells.</span></span></span></span></p>",
      "correct_choice_id": 203417,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11519,
      "choices": [
        {
          "id": 46042,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BP &gt; 160/90 mmHg with one anti-hypertensive</span></span></span></span></p>"
        },
        {
          "id": 46043,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BP &gt; 140/90 mmHg with one anti-hypertensive</span></span></span></span></p>"
        },
        {
          "id": 46044,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BP &gt; 140/90 mmHg with three or more anti hypertensives</span></span></span></span></p>"
        },
        {
          "id": 46045,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BP &gt; 160/90 mmHg with three or more anti hypertensives</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Resistant hypertension is defined as? (AIIMS MAY 2020)</span></span></p>",
      "unique_key": "Q5665159",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934879,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BP &gt; 140/90 mmHg with three or more anti hypertensives.</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Resistant hypertension is defined as blood pressure that remains above goal despite the concurrent use of three anti-hypertensive agents of different classes. Typically, one of the three medications should be a diuretic, and all agents should be prescribed at optimal dose amounts. The threshold set for defining resistant hypertension is blood pressure greater than 140/90 mmHg.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Resistant hypertension indicates a situation where blood pressure control is inadequate despite the use of multiple medications, which can pose significant risks for cardiovascular complications and requires careful evaluation for secondary causes. This includes assessing for white-coat HTN/Pseudo HTN, medication adherence, lifestyle factors, and secondary causes of hypertension like renal artery stenosis, endocrine disorders, or medication-induced hypertension.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Home BP monitoring, ABPM (Ambulatory BP monitoring) can help in optimization of drugs.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Resistant HTN refers to BP &gt; 140/90 mmHg despite three anti-HTN, <em>one being a diuretic.</em></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison 21E/Cardiology/Hypertensive Disease/ chap 277&nbsp;&nbsp;&nbsp; </span></span></strong></span></span></p>",
      "correct_choice_id": 46044,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11324,
      "choices": [
        {
          "id": 45262,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Coarctation of aorta</span></span></p>"
        },
        {
          "id": 45263,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atrial septal defect</span></span></p>"
        },
        {
          "id": 45264,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bicuspid aortic valve</span></span></p>"
        },
        {
          "id": 45265,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patent ductus arteriosus</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A male patient had feeble femoral pulses with an upper-limb blood pressure of 186/90 mmHg. Chest X-ray showed enlarged intercostal arteries. What is the likely diagnosis?</span> <span style=\"font-size:12.0pt\">(NEET PG 2021)</span></span></span></p>",
      "unique_key": "Q7506833",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934880,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A. Coarctation of aorta</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Coarctation of the aorta is a congenital condition characterized by the narrowing of the aorta, which causes an obstruction to blood flow. This condition leads to high blood pressure in the arteries that are proximal to the narrowing (upper limbs) and lower blood pressure in the arteries distal to the narrowing (lower limbs).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The key findings in this scenario include:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Feeble femoral pulses</span></strong><span style=\"font-size:12.0pt\">: Due to reduced blood flow past the coarctation.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Upper limb hypertension</span></strong><span style=\"font-size:12.0pt\">: Caused by increased resistance proximal to the coarctation.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Chest X-ray showing enlarged intercostal arteries</span></strong><span style=\"font-size:12.0pt\">: These develop as collateral circulation to bypass the coarctation, which can cause rib notching seen on X-ray.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Atrial septal defect (ASD):</span></strong><span style=\"font-size:12.0pt\"> An ASD is a hole in the septum between the heart&#39;s atria. It typically causes a left-to-right shunt and can lead to increased pulmonary blood flow and right heart overload. It does not cause differential blood pressure between limbs or enlarged intercostal arteries.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Bicuspid aortic valve:</span></strong><span style=\"font-size:12.0pt\"> A bicuspid aortic valve is a congenital valve anomaly that can lead to aortic stenosis or regurgitation but does not typically cause differential blood pressure between the limbs or enlarged intercostal arteries.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Patent ductus arteriosus (PDA):</span></strong><span style=\"font-size:12.0pt\"> A PDA is a persistent opening between the aorta and the pulmonary artery. It causes a continuous murmur and can lead to heart failure if significant but does not cause differential blood pressure or enlarged intercostal arteries.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Coarctation of the aorta should be suspected in patients with a significant difference in blood pressure between the upper and lower limbs, feeble femoral pulses, and chest X-ray findings of enlarged intercostal arteries, indicating collateral circulation.</span></span></p>",
      "correct_choice_id": 45262,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11960,
      "choices": [
        {
          "id": 47805,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rectum</span></span></p>"
        },
        {
          "id": 47806,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Colon</span></span></p>"
        },
        {
          "id": 47807,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Small intestine</span></span></p>"
        },
        {
          "id": 47808,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ileocecal junction</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">What is the most common site of abdominal tuberculosis? (INICET NOV 2022)</span></span></span></p>",
      "unique_key": "Q5610317",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934881,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Ileocecal junction</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The ileocecal junction is the most common site of abdominal tuberculosis. This area, which includes the terminal ileum and the beginning of the large intestine (cecum), is particularly susceptible to infection by Mycobacterium tuberculosis. The lymphoid tissue in this region provides a favorable environment for the bacteria to proliferate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Abdominal tuberculosis can present in two primary forms: <strong>hypertrophic and ulcerative. </strong>The hypertrophic form involves thickening of the intestinal wall, while the ulcerative form leads to the formation of ulcers. Clinically, differentiating abdominal tuberculosis from Crohn&#39;s disease can be challenging due to overlapping symptoms and similar radiologic findings. In some cases, empirical anti-tubercular therapy (ATP) may be initiated, with subsequent monitoring for clinical improvement to help distinguish between the two conditions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Rectum:</span></strong><span style=\"font-size:12.0pt\"> The rectum is not a common site for abdominal tuberculosis. Tuberculosis primarily affects the ileocecal region and less frequently involves other parts of the gastrointestinal tract.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Colon:</span></strong><span style=\"font-size:12.0pt\"> While tuberculosis can affect the colon, it is not the most common site. The ileocecal junction is more frequently involved in abdominal tuberculosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Small intestine:</span></strong><span style=\"font-size:12.0pt\"> Although the small intestine can be affected, the terminal ileum specifically, which is part of the ileocecal junction, is the most common site for tuberculosis within the small intestine.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most common site of abdominal tuberculosis is the ileocecal junction, particularly near the terminal ileum. This region&#39;s lymphoid tissue creates a favorable environment for Mycobacterium tuberculosis to proliferate.</span></span></span></p>",
      "correct_choice_id": 47808,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20274,
      "choices": [
        {
          "id": 81057,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pseudogout</span></span></span></p>"
        },
        {
          "id": 81058,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute gout</span></span></span></p>"
        },
        {
          "id": 81059,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Reactive arthritis</span></span></span></p>"
        },
        {
          "id": 81060,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Septic arthritis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A chronic alcoholic patient presents with acute pain and swelling of the left great toe. There is no history of trauma. Synovial fluid analysis shows raised leukocytes. Lab investigations show normal serum uric acid levels. What is the most likely diagnosis? (NEET PG 2023)</span></span></span></p>",
      "unique_key": "Q2994041",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934882,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B. Acute gout</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient presents with acute pain and swelling in the left great toe, a common presentation of acute gout. Despite normal serum uric acid levels, the clinical presentation and the findings from the synovial fluid analysis point towards acute gout.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Key Findings:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Acute Pain and Swelling of the Left Great Toe:</span></strong><span style=\"font-size:12.0pt\"> This is characteristic of acute gout, especially involving the first metatarsophalangeal (MTP) joint.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">No History of Trauma:</span></strong><span style=\"font-size:12.0pt\"> This excludes traumatic causes of joint pain.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Synovial Fluid Analysis Shows Raised Leukocytes:</span></strong><span style=\"font-size:12.0pt\"> Indicates an inflammatory arthritis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Normal Serum Uric Acid Levels:</span></strong><span style=\"font-size:12.0pt\"> In 30-40% of acute gout cases, serum uric acid levels can be normal due to the uric acid being sequestered in the joint rather than in the bloodstream.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Acute Gout&nbsp;</span></strong><span style=\"font-size:12.0pt\">is a form of inflammatory arthritis caused by the deposition of monosodium urate crystals in joints, leading to intense pain and swelling. The first MTP joint is the most commonly affected site. Acute gout can present with normal serum uric acid levels, particularly during an acute attack, due to the uric acid being sequestered in the joint.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Diagnosis Confirmation:</span></strong><span style=\"font-size:12.0pt\"> The diagnosis of gout is confirmed by joint aspiration and identification of negatively birefringent needle-shaped crystals under polarized light microscopy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Pseudogout:</span></strong><span style=\"font-size:12.0pt\"> This condition usually presents in <strong>elderly individuals</strong> and often involves the knee or wrist joints. The presence of <strong>chondrocalcinosis on X-ray</strong> and the involvement of joints like knee (MC), wrist or MCP joint (NOT first MTP joint) makes pseudogout less likely in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Reactive Arthritis:</span></strong><span style=\"font-size:12.0pt\"> This condition typically follows a gastrointestinal or genitourinary infection and involves multiple joints. There is no mention of such a history in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Septic Arthritis:</span></strong><span style=\"font-size:12.0pt\"> This condition is usually associated with more severe systemic symptoms like fever and a more aggressive clinical course. The patient&#39;s presentation does not match the typical features of septic arthritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educaitonal Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute gout can present with normal serum uric acid levels, especially during an acute attack, and the involvement of the first metatarsophalangeal (MTP) joint is highly characteristic of this condition.</span></span></p>",
      "correct_choice_id": 81058,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 46779,
      "choices": [
        {
          "id": 186731,
          "text": "<p><span style=\"font-size:12.0pt;\">Urine output &lt; 100 ml/hr</span></p>"
        },
        {
          "id": 186732,
          "text": "<p><span style=\"font-size:12.0pt;\">Urine output &lt; 400 ml/hr</span></p>"
        },
        {
          "id": 186733,
          "text": "<p><span style=\"font-size:12.0pt;\">Urine output &lt; 800 ml/hr</span></p>"
        },
        {
          "id": 186734,
          "text": "<p><span style=\"font-size:12.0pt;\">Urine output &lt; 1200 ml/hr</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Anuria in clinical practice is defined as:(NEET PG 2014)</span></p>",
      "unique_key": "Q8777592",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934883,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Urine output &lt; 100 ml/hr</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Anuria in clinical practice is defined as the passage of less than 100 ml of urine in a day. This definition is crucial for diagnosing severe kidney dysfunction where the kidneys fail to produce urine. Understanding the definitions of various urine outputs helps in differentiating between different levels of renal impairment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/31/screenshot-2024-05-31-182556.JPG\" alt=\"\" width=\"710\" height=\"447\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Anuria</strong>: Defined as a urine output of less than 100 ml per day. This condition indicates severe kidney failure and requires immediate medical intervention.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Oliguria</strong>: Defined as a urine output of less than 400 ml per day, which is the minimum amount of urine needed to excrete daily solute production in a normal metabolic state.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong> <strong>B. Urine output &lt; 400 ml/hr</strong>: Incorrect, as this definition applies to oliguria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong> <strong>C. Urine output &lt; 800 ml/hr</strong>: Incorrect, as this does not fit the clinical definitions of anuria or oliguria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong> <strong>D. Urine output &lt; 1200 ml/hr</strong>: Incorrect, as this is above the threshold for normal urine output.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Anuria is defined as urine output of less than 100 ml per day, indicating severe kidney dysfunction.</span></p>",
      "correct_choice_id": 186731,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44839,
      "choices": [
        {
          "id": 179003,
          "text": "<p><span style=\"font-size:16px;\">Congenital red cell aplasia</span></p>"
        },
        {
          "id": 179004,
          "text": "<p><span style=\"font-size:16px;\">Hereditary spherocytosis</span></p>"
        },
        {
          "id": 179005,
          "text": "<p><span style=\"font-size:16px;\">Hemolytic disease of the newborn</span></p>"
        },
        {
          "id": 179006,
          "text": "<p><span style=\"font-size:16px;\">G6PD deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A positive direct antiglobulin (Coombs) test indicates:</span></p>",
      "unique_key": "Q6780744",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934884,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Hemolytic disease of the newborn</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">A positive direct antiglobulin test (DAT), also known as the direct Coombs test, indicates that antibodies or complement proteins are bound to the surface of red blood cells. This test is commonly used to diagnose hemolytic disease of the newborn (HDN). HDN occurs when maternal antibodies cross the placenta and target fetal red blood cells, leading to their destruction. This immune-mediated hemolysis results in neonatal anemia and hyperbilirubinemia. The positive DAT confirms the presence of these antibodies on the fetal red blood cells, supporting the diagnosis of HDN.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Congenital red cell aplasia:</strong> This is a non-immune condition where there is a failure in red blood cell production, not related to antibody-mediated hemolysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Hereditary spherocytosis:</strong> This is a non-immune hemolytic anemia caused by a defect in the red cell membrane, leading to spherical-shaped red cells that are prone to hemolysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. G6PD deficiency:</strong> This is a non-immune hemolytic anemia caused by an enzyme deficiency that makes red blood cells more susceptible to oxidative stress.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">A positive direct anti-globulin (Coombs) test is indicative of hemolytic disease of the newborn, an immune-mediated condition.</span></p>",
      "correct_choice_id": 179005,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11416,
      "choices": [
        {
          "id": 45630,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Subclinical hypothyroidism</span></span></span></span></p>"
        },
        {
          "id": 45631,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hyperthyroidism</span></span></span></span></p>"
        },
        {
          "id": 45632,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Secondary hypothyroidism</span></span></span></span></p>"
        },
        {
          "id": 45633,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Primary hypothyroidism</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">On thyroid function test analysis, TSH value was much higher than normal with low free T4. What is the diagnosis? (AIIMS MAY 2017)</span></span></span></p>",
      "unique_key": "Q7003059",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934885,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Primary hypothyroidism</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HYPOTHYROIDISM</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Types:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Primary Hypothyroidism</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - Increased TSH with low T4 levels. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Secondary hypothyroidism </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">- TSH can be low, normal or elevated slightly. The latter is due to secretion of immune-active but bio-active forms of TSH. Confirmation of diagnosis is done by detecting low levels of unbound T4. </span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Evaluation of Hypothyroidism:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture30.jpg\" style=\"height:362px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Subclinical hypothyroidism:</span></strong><span style=\"font-size:12.0pt\"> Incorrect because subclinical hypothyroidism would show an elevated TSH but normal free T4 levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Hyperthyroidism:</span></strong><span style=\"font-size:12.0pt\"> Incorrect as hyperthyroidism would typically present with low TSH and high free T4 levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Secondary hypothyroidism:</span></strong><span style=\"font-size:12.0pt\"> Incorrect for this scenario because secondary hypothyroidism involves a problem with pituitary TSH production, which does not typically result in a significantly elevated TSH.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The primary hypothyroidism is characterized by high TSH and low free T4 levels, indicating a failure of the thyroid gland itself to produce sufficient hormones.</span></span></span></p>",
      "correct_choice_id": 45633,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11216,
      "choices": [
        {
          "id": 44830,
          "text": "<p><span style=\"font-size:12.0pt;\">Brugada syndrome</span></p>"
        },
        {
          "id": 44831,
          "text": "<p><span style=\"font-size:12.0pt;\">Ventricular fibrillation</span></p>"
        },
        {
          "id": 44832,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute coronary syndrome with low EF</span></p>"
        },
        {
          "id": 44833,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Automatic implantable cardioverter-defibrillator (AICD) implantation is done for which of the following conditions? (NEET PG 2018)</span></p>",
      "unique_key": "Q8392836",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934886,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. All of the above</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">An Automatic Implantable Cardioverter-Defibrillator (AICD) is used for the prevention of sudden cardiac death in patients with various cardiac conditions that predispose them to life-threatening arrhythmias. The indications include:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Brugada syndrome:&nbsp;</strong>A genetic disorder that can lead to dangerous ventricular arrhythmias.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ventricular fibrillation (VF):&nbsp;</strong>A life-threatening heart rhythm that results in rapid, inadequate heartbeats.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Acute coronary syndrome (ACS) with low ejection fraction (EF):&nbsp;</strong>After a myocardial infarction, patients with significantly reduced EF are at higher risk for ventricular arrhythmias.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The device is particularly beneficial in patients with structural heart disease, prior myocardial infarction, and those who have experienced syncope due to undetermined reasons but are found to have inducible ventricular tachycardia or fibrillation during electrophysiological studies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Class I Indications for AICD implantation:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">LV dysfunction with ejection fraction less than or equal to 35% and NYHA II/III symptoms.</span></li><li><span style=\"font-size:12.0pt;\">LV dysfunction with ejection fraction less than or equal to 35% due to previous Myocardial Infarction (MI) or at least 40 days post-MI and NYHA II/III symptoms.</span></li><li><span style=\"font-size:12.0pt;\">LV dysfunction with ejection fraction less than or equal to 30% due to previous Myocardial Infarction (MI) or at least 40 days post-MI.</span></li><li><span style=\"font-size:12.0pt;\">LV dysfunction with ejection fraction less than or equal to 40% due to previous Myocardial Infarction (MI) or at least 40 days post-MI and inducible VT/VF on EP study (EPS).</span></li><li><span style=\"font-size:12.0pt;\">Syncope of unknown etiology and inducible VT/ VF on EPS.</span></li><li><span style=\"font-size:12.0pt;\">Sustained VT in the presence of structural heart disease.</span></li><li><span style=\"font-size:12.0pt;\">Brugada syndrome.</span></li><li><span style=\"font-size:12.0pt;\">HCM with &gt; 1 risk factor for SCD.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21/Ventricular Arrhythmias/Chapter 252</strong></span></p>",
      "correct_choice_id": 44833,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47532,
      "choices": [
        {
          "id": 189739,
          "text": "<p><span style=\"font-size:12.0pt;\">Duke's criteria</span></p>"
        },
        {
          "id": 189740,
          "text": "<p><span style=\"font-size:12.0pt;\">Light criteria</span></p>"
        },
        {
          "id": 189741,
          "text": "<p><span style=\"font-size:12.0pt;\">Beer's criteria</span></p>"
        },
        {
          "id": 189742,
          "text": "<p><span style=\"font-size:12.0pt;\">Jones criteria</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An elderly male patient who is a known case of COPD, hypertension, and diabetes mellitus visits the OPD to review his medications. Which of the following criteria should be followed by the physician during the review?</span></p>",
      "unique_key": "Q5508303",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934887,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Beer's criteria</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Beer's criteria is a guideline used by physicians to help improve the safety of prescribing medications for older adults. It is specifically designed to <strong>avoid potentially inappropriate medications that can cause adverse drug reactions</strong> and interactions in the <strong>elderly</strong> individuals.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Duke's criteria:&nbsp;</strong>Used for diagnosing infective endocarditis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Light criteria:&nbsp;</strong>Used for diagnosing exudative pleural effusions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Jones criteria:&nbsp;</strong>Used for diagnosing acute rheumatic fever.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Beer's criteria should be used by physicians to review and manage medications in elderly patients to minimize the risk of adverse effects and drug interactions.</span></p>",
      "correct_choice_id": 189741,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24780,
      "choices": [
        {
          "id": 99081,
          "text": "<p><span style=\"font-size:12.0pt;\">1,2,3,4</span></p>"
        },
        {
          "id": 99082,
          "text": "<p><span style=\"font-size:12.0pt;\">1,2</span></p>"
        },
        {
          "id": 99083,
          "text": "<p><span style=\"font-size:12.0pt;\">3,4</span></p>"
        },
        {
          "id": 99084,
          "text": "<p><span style=\"font-size:12.0pt;\">2,3,4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female with nephrotic syndrome underwent a renal biopsy. Which of the following statements is correct? (INICET MAY 2023)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">FSGS cannot be diagnosed by a percutaneous renal biopsy</span></li><li><span style=\"font-size:12.0pt;\">Patient should be observed for 24 hours following biopsy</span></li><li><span style=\"font-size:12.0pt;\">Dark red clots in the urine following a biopsy indicate a hematoma</span></li><li><span style=\"font-size:12.0pt;\">Patients with features of systemic amyloidosis and renal involvement can undergo abdominal fat pad biopsy instead of renal biopsy</span></li></ol>",
      "unique_key": "Q1461879",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934888,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 2,3,4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Following a renal biopsy, it is crucial to monitor the patient for potential complications, including bleeding and hematoma formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Observation post-biopsy:</strong> Patients should be observed for 24 hours following a renal biopsy to monitor for complications such as bleeding or infection.</span></p><p style=\"margin-left:24px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Dark red clots in urine: </strong>Dark red clots in the urine following a biopsy can indicate a hematoma. This is a potential complication that needs to be monitored.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Abdominal fat pad biopsy:</strong> Patients with systemic amyloidosis and renal involvement can undergo an abdominal fat pad biopsy as an alternative to a renal biopsy. This method can help diagnose systemic amyloidosis with less risk compared to a renal biopsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. FSGS cannot be diagnosed by a percutaneous renal biopsy</strong>: This statement is incorrect. Focal segmental glomerulosclerosis (FSGS) can indeed be diagnosed by a percutaneous renal biopsy. The biopsy helps in identifying the characteristic histological changes associated with FSGS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Post-biopsy observation, recognition of biopsy-related complications, and alternative biopsy methods for systemic amyloidosis are essential in nephrotic syndrome management.</span></p>",
      "correct_choice_id": 99084,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11751,
      "choices": [
        {
          "id": 46970,
          "text": "<p><span style=\"font-size:12.0pt;\">LDH</span></p>"
        },
        {
          "id": 46971,
          "text": "<p><span style=\"font-size:12.0pt;\">Troponin-T</span></p>"
        },
        {
          "id": 46972,
          "text": "<p><span style=\"font-size:12.0pt;\">CKMB</span></p>"
        },
        {
          "id": 46973,
          "text": "<p><span style=\"font-size:12.0pt;\">BNP</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presented with the complaints of chest pain. Which among the following is the best investigation to diagnose MI within 2-4 hours? (INICET NOV 2020)</span></p>",
      "unique_key": "Q7231088",
      "question_audio": null,
      "question_video": null,
      "map_id": 15934889,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)&nbsp;Troponin â T</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Troponin-T is the most sensitive and specific biomarker available for diagnosing myocardial infarction (MI) within the early hours of symptom onset. It begins to rise within 3-4 hours of myocardial damage, peaks at around 12-48 hours, and remains elevated for up to 7-10 days, making it highly useful for early diagnosis and detection of recent heart damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. LDH:</strong>&nbsp;it is a less specific enzyme that may be elevated in many types of tissue damage and is not ideal for early diagnosis of MI.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. CKMB: it&nbsp;</strong>rises within 4-8 hours of myocardial injury, making it less useful than Troponin-T in the very early stages post-symptom onset.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. BNP:&nbsp;</strong>it is primarily used to assess heart failure and is not a primary marker for acute myocardial infarction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-110113.png\" alt=\"\" width=\"1000\" height=\"414\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rise by &gt;20%of troponin is used for diagnosis of Reinfarction</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Newer biomarkers: HFABP, miRNA1,21,33</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - (Cardiology/Biomarkers, MI)</strong></span></p>",
      "correct_choice_id": 46971,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11256,
      "choices": [
        {
          "id": 44990,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute motor axonal neuropathy</span></span></span></span></p>"
        },
        {
          "id": 44991,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute inflammatory demyelinating polyneuropathy</span></span></span></span></p>"
        },
        {
          "id": 44992,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute motor sensory axonal neuropathy</span></span></span></span></p>"
        },
        {
          "id": 44993,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Miller Fisher syndrome</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the most common type of Guillain-Barre syndrome? (NEET PG 2019)</span></span></p>",
      "unique_key": "Q8007814",
      "question_audio": null,
      "question_video": null,
      "map_id": 15935010,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Acute inflammatory demyelinating polyneuropathy</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute inflammatory demyelinating polyneuropathy (AIDP) is the most common form of Guillain-Barre syndrome (GBS) in the United States and Europe. It presents with rapidly ascending motor weakness and, at times, sensory disturbances in the form of paresthesia. The pathological hallmark of AIDP is the demyelination of peripheral nerves, leading to slow nerve conduction velocities as detected on electromyography.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Acute motor axonal neuropathy (AMAN):&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While AMAN is more common in certain regions like East Asia, it is less prevalent than AIDP in most parts of the world. AMAN is characterized by the involvement of motor fibers without significant demyelination.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Acute motor sensory axonal neuropathy (AMSAN):&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Similar to AMAN but involves both motor and sensory fibers. It is generally more severe but less common than AIDP.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Miller Fisher syndrome:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A rare variant of GBS that is characterized by ataxia, areflexia, and ophthalmoplegia. It is considered a variant of GBS associated with anti-GQ1b antibodies.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AIDP is the <strong>most common type of GBS</strong> presenting with ascending motor weakness with occasional distal sensory paresthesia due to demyelination of posterior column.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Axonal variants:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AMAN (Acute motor axonal neuropathy):&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GM1a, GD1a&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AMSAN (Acute motor &amp; sensory axonal neuropathy):&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GM1a, GD1a&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other variants</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute motor conduction block neuropathy: <strong>GM1a, GD1a</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pharyngo-cervico-branchial variant: <strong>GT1a</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Miller-Fischer variant: <strong>GQ1b &gt;&gt; GT1a</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute ataxic neuropathy: <strong>GQ1b &gt;&gt; GT1a</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pure sensory ataxic variant: <strong>GD1b</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bickerstaff brainstem encephalitis (BBE): <strong>GQ1 &gt;&gt; GT1a</strong></span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Adam and Viktor/Peripheral neuropathy/GBS page 1322</span></span></strong></p>",
      "correct_choice_id": 44991,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11616,
      "choices": [
        {
          "id": 46430,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Reduce FiO2</span></span></span></p>"
        },
        {
          "id": 46431,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increase tidal volume</span></span></span></p>"
        },
        {
          "id": 46432,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increase respiratory rate</span></span></span></p>"
        },
        {
          "id": 46433,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increase PEEP</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 65-year-old female patient weighing 60 kg is on mechanical ventilation for ARDS secondary to urosepsis.&nbsp;</span></span></span><span style=\"font-family:Calibri,sans-serif; font-size:12pt\">The respiratory parameters are as follows: tidal volume- 360 mL; frequency- 30 breaths/min; PEEP- 5 cm of H2O; and FiO2- 90%.&nbsp;</span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The arterial blood gas findings are as follows: paO2- 50 mmHg; paCO2- 38 mmHg and pH- 7.38.&nbsp;</span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">What is the next step?</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>",
      "unique_key": "Q4970510",
      "question_audio": null,
      "question_video": null,
      "map_id": 15935011,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Increase PEEP</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute Respiratory Distress Syndrome (ARDS) requires careful management of mechanical ventilation settings to optimize oxygenation while minimizing lung injury. The patient&#39;s current settings and blood gas findings suggest hypoxemia (paO2 of 50 mmHg) with an FiO2 of 90%. The goal in managing ARDS is to maintain adequate oxygenation (paO2 &gt; 60 mmHg) while reducing the FiO2 to less than 60% to avoid oxygen toxicity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increasing PEEP is the best option to improve oxygenation. PEEP helps to keep alveoli open, improving gas exchange and oxygenation. By increasing PEEP, we can potentially increase the paO2 and eventually reduce the FiO2 to safer levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Reduce FiO2</strong>: Although reducing FiO2 is a long-term goal to prevent oxygen toxicity, it is not advisable to reduce it immediately because the patient is currently hypoxemic (paO2 of 50 mmHg).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Increase tidal volume</strong>: Not appropriate as it can increase the risk of ventilator-induced lung injury in ARDS patients. The current tidal volume is within the safe range (360 mL), which is appropriate for a 60 kg patient as it falls within the recommended range of 4-6 mL/kg for ARDS patients to prevent ventilator-induced lung injury.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Increase respiratory rate</strong>: Increasing the respiratory rate is not necessary in this situation as the paCO2 (38 mmHg) and pH (7.38) indicate normal ventilation and no significant respiratory acidosis (paCO2 is normal).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In ARDS management, if the patient remains hypoxemic despite a high FiO2, the next step is to increase the PEEP to improve oxygenation while maintaining lung-protective ventilation strategies.</span></span></span></p>",
      "correct_choice_id": 46433,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16181,
      "choices": [
        {
          "id": 64684,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Inclusion body myositis</span></span></span></p>"
        },
        {
          "id": 64685,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dermatomyositis</span></span></span></p>"
        },
        {
          "id": 64686,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Polymyositis</span></span></span></p>"
        },
        {
          "id": 64687,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Scleroderma</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 50-year-old woman presented with difficulty in activities like climbing stairs, getting up from a chair, and combing hair. Violaceous erythema of the upper eyelids was noted. What is the most probable diagnosis? (FMGE JAN 2023)</span></span></span></p>",
      "unique_key": "Q1970641",
      "question_audio": null,
      "question_video": null,
      "map_id": 15935012,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>B) Dermatomyositis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The patient&#39;s symptoms of difficulty in climbing stairs, getting up from a chair, and combing hair suggest proximal muscle weakness, a key feature of myopathy. The presence of violaceous erythema of the upper eyelids, known as heliotrope rash, strongly indicates dermatomyositis. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dermatomyositis is characterized by both muscle inflammation and distinctive skin rashes, and it is commonly associated with <strong>anti-Mi-2 antibodies</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Inclusion body myositis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Typically presents with asymmetric muscle weakness and does not usually involve skin rashes like dermatomyositis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Polymyositis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Also involves proximal muscle weakness but lacks the characteristic skin manifestations seen in dermatomyositis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Scleroderma:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Primarily affects the skin with hardening and tightening but does not typically present with proximal muscle weakness or the specific rash of dermatomyositis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Proximal muscle weakness combined with characteristic skin rashes, such as heliotrope rash, is indicative of dermatomyositis.</span></span></span></p>",
      "correct_choice_id": 64685,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54272,
      "choices": [
        {
          "id": 216557,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SGLT2 inhibitors</span></span></p>"
        },
        {
          "id": 216558,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Finerenone</span></span></p>"
        },
        {
          "id": 216559,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydrochlorothiazide</span></span></p>"
        },
        {
          "id": 216560,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Angiotensin receptor blockers</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 55-year-old patient with type 2 diabetes mellitus is being evaluated for medications to manage their condition and prevent renal complications. Which of the following drugs will not delay progression of renal disease?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q2297921",
      "question_audio": null,
      "question_video": null,
      "map_id": 15935013,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Hydrochlorothiazide</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hydrochlorothiazide is a thiazide diuretic primarily used to treat hypertension and edema. It is not specifically known to delay the progression of renal disease in patients with type 2 diabetes mellitus. While it helps in managing blood pressure, it does not have the protective renal effects seen with other medications listed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. SGLT2 inhibitors:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> These drugs, such as dapagliflozin and empagliflozin, have been shown to provide renal protection by reducing the progression of kidney disease in patients with type 2 diabetes. They work by decreasing glucose reabsorption in the kidneys, leading to osmotic diuresis and reduced glomerular hyperfiltration.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Finerenone:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a non-steroidal mineralocorticoid receptor antagonist (MRA) approved for the treatment of chronic kidney disease in type 2 diabetes. It helps to reduce albuminuria and slows the progression of renal disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Angiotensin receptor blockers (ARBs):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> ARBs, such as losartan and valsartan, are well-known for their renal protective effects. They help reduce proteinuria and slow the progression of diabetic nephropathy by blocking the effects of angiotensin II on the kidneys.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hydrochlorothiazide does not delay the progression of renal disease in patients with type 2 diabetes. In contrast, SGLT2 inhibitors, finerenone, and angiotensin receptor blockers are all known to provide renal protection and slow the progression of diabetic kidney disease.</span></span></span></p>",
      "correct_choice_id": 216559,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11289,
      "choices": [
        {
          "id": 45122,
          "text": "<p><span style=\"font-size:12.0pt;\">42 degree C</span></p>"
        },
        {
          "id": 45123,
          "text": "<p><span style=\"font-size:12.0pt;\">37 degree C</span></p>"
        },
        {
          "id": 45124,
          "text": "<p><span style=\"font-size:12.0pt;\">32 degree C</span></p>"
        },
        {
          "id": 45125,
          "text": "<p><span style=\"font-size:12.0pt;\">30 degree C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The recommended temperature of water bath for a patient with frost bite is? (NEET PG 2020)</span></p>",
      "unique_key": "Q5064729",
      "question_audio": null,
      "question_video": null,
      "map_id": 15935014,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. 37 degrees C</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Frostbite should be managed with rapid and complete thawing using a circulating water bath maintained between 37Â°C and 40Â°C. This temperature range is optimal to reverse vascular stasis and initiate reperfusion without causing thermal injury.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thawing at this range is typically performed for 30 to 60 minutes and should be done only when the possibility of refreezing is excluded. Higher temperatures like 42Â°C are not recommended and may worsen tissue injury.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 42Â°C</strong>: Too hot. It exceeds the upper recommended limit and can risk thermal damage to already compromised tissue.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 32Â°C</strong>: Insufficient to produce effective rewarming. Rewarming would be slow and incomplete.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 30Â°C</strong>: Ineffective. Tissue remains partially frozen and vulnerable to re-freezing injury.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Frostbite should be rewarmed in circulating water at 37â40Â°C for 30â60 minutes, avoiding hot air or dry heat.</span></p>",
      "correct_choice_id": 45123,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47619,
      "choices": [
        {
          "id": 190087,
          "text": "<p><span style=\"font-size:12.0pt;\">Asthma</span></p>"
        },
        {
          "id": 190088,
          "text": "<p><span style=\"font-size:12.0pt;\">Pneumonia</span></p>"
        },
        {
          "id": 190089,
          "text": "<p><span style=\"font-size:12.0pt;\">Bronchiectasis</span></p>"
        },
        {
          "id": 190090,
          "text": "<p><span style=\"font-size:12.0pt;\">Lung cancer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 48-year-old smoker presents with yellow, copious, foul-smelling sputum that increases significantly in the morning after getting up and on changing posture. He has had this problem for a few years. What will be the first differential diagnosis? (</span>FMGE Jan 2024)</p>",
      "unique_key": "Q9098769",
      "question_audio": null,
      "question_video": null,
      "map_id": 15935015,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Bronchiectasis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct answer is bronchiectasis. The key features in this case include the presence of copious, foul-smelling sputum that increases significantly in the morning and with postural changes. These features are highly suggestive of bronchiectasis, a condition characterized by chronic dilation and infection of the bronchi. This leads to the production of large amounts of sputum, particularly after changes in posture due to the drainage of secretions from the dilated airways.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Asthma:&nbsp;</strong>Typically presents with wheezing, shortness of breath, and a dry or mildly productive cough. Asthma is diagnosed with spirometry, showing reversible airway obstruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Pneumonia:&nbsp;</strong>Usually presents acutely with fever, cough, and purulent sputum. It is less likely to cause symptoms that have persisted for years.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Lung cancer:&nbsp;</strong>May present with chronic cough and hemoptysis but is less likely to produce copious, foul-smelling sputum that increases with postural changes over several years.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bronchiectasis should be considered in patients with chronic, copious, foul-smelling sputum that varies with posture, especially in the context of a history of smoking or recurrent respiratory infections. Recognizing these features can prompt appropriate diagnostic imaging, such as a CT scan showing characteristic tram-track or signet ring appearances.</span></p>",
      "correct_choice_id": 190089,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 66110,
      "choices": [
        {
          "id": 263585,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoventilation causing decreased CO2 washout</span></p>"
        },
        {
          "id": 263586,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperventilation causing increased CO2 washout</span></p>"
        },
        {
          "id": 263587,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased tubular reabsorption of HCO3-</span></p>"
        },
        {
          "id": 263588,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased excretion of H+</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The arterial blood gas analysis findings of a patient are as follows: pH = 7.30, HCO3 = 10 mEq/L, PaCO2 = 20 mmHg, which is suggestive of partially compensated metabolic acidosis. What is the mechanism for the secondary disorder? (Twisted PYQ)</span></p>",
      "unique_key": "Q8223628",
      "question_audio": null,
      "question_video": null,
      "map_id": 15935016,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Hyperventilation causing increased CO2 washout</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The ABG values indicate metabolic acidosis (low HCO3 with a low pH). The PaCO2 is 20 mmHg, which is lower than the expected value calculated using Winter's formula:</span></p><p><span style=\"font-size:12.0pt;\">Expected PaCO2 = (1.5 Ã HCO3) + 8 Â± 2 = (1.5 Ã 10) + 8 Â± 2 = 23 Â± 2 mmHg.</span></p><p><span style=\"font-size:12.0pt;\">The observed PaCO2 (20 mmHg) is lower than the expected value, indicating excessive respiratory compensation through hyperventilation, leading to increased CO2 washout.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hypoventilation causing decreased CO2 washout</strong>: This would result in a higher-than-expected PaCO2, worsening acidosis, and does not explain the observed findings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Increased tubular reabsorption of HCO3</strong>-: This mechanism compensates for metabolic acidosis but does not explain the respiratory findings here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Decreased excretion of H+</strong>: This would exacerbate metabolic acidosis rather than represent a compensatory response.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In metabolic acidosis, respiratory compensation via hyperventilation aims to reduce PaCO2, mitigating the acidosis. Comparing measured PaCO2 with the expected value helps identify appropriate or excessive respiratory compensation. Hyperventilation leading to increased CO2 washout is a common compensatory mechanism in metabolic acidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Harrison/Acid-Base Disorders/Chapter 318</strong></span></p>",
      "correct_choice_id": 263586,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11460,
      "choices": [
        {
          "id": 45806,
          "text": "<p><span style=\"font-size:12.0pt;\">Cryoglobulinemic vasculitis</span></p>"
        },
        {
          "id": 45807,
          "text": "<p><span style=\"font-size:12.0pt;\">Polyarteritis nodosa</span></p>"
        },
        {
          "id": 45808,
          "text": "<p><span style=\"font-size:12.0pt;\">EGPA</span></p>"
        },
        {
          "id": 45809,
          "text": "<p><span style=\"font-size:12.0pt;\">Giant cell arteritis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A triad of skin lesions, asymmetric mononeuritis multiplex and eosinophilia is seen in which of the following conditions? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q2949063",
      "question_audio": null,
      "question_video": null,
      "map_id": 15935017,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) EGPA</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Eosinophilic Granulomatosis with Polyangiitis (EGPA), formerly known as Churg-Strauss Syndrome, is characterized by a combination of <strong>asthma, eosinophilia, and vasculitis </strong>affecting multiple organ systems.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical triad of skin lesions (such as purpura or nodules), asymmetric mononeuritis multiplex (manifesting as numbness, pain, or muscle weakness typically in the limbs), and eosinophilia is highly suggestive of this condition. EGPA is a type of ANCA-associated vasculitis but differs from others in its prominent eosinophilic involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cryoglobulinemic vasculitis:&nbsp;</strong>Typically associated with hepatitis C infection and features immune complexes in the blood that precipitate in the cold. It commonly presents with palpable purpura, joint pains, and kidney involvement but not typically with eosinophilia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Polyarteritis nodosa (PAN):&nbsp;</strong>A medium vessel vasculitis that may present with similar features including neuropathy and skin lesions but does not typically include eosinophilia as a prominent feature.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Giant cell arteritis (GCA):&nbsp;</strong>Primarily affects large vessels, particularly the temporal arteries, and presents with symptoms such as headache, jaw claudication, and potential blindness. It does not feature the triad of skin lesions, mononeuritis multiplex, and eosinophilia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">EGPA is a distinctive form of vasculitis marked by asthma, eosinophilia, and a systemic vasculitis involving skin and nerves among other systems. Its recognition is crucial due to the need for early and aggressive treatment to prevent significant morbidity and mortality.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture55.jpg\" alt=\"\" width=\"1000\" height=\"554\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Rheumatology/Vasculitis/Chap 363</strong></span></p>",
      "correct_choice_id": 45808,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11805,
      "choices": [
        {
          "id": 47186,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iloprost</span></span></p>"
        },
        {
          "id": 47187,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ambrisentan</span></span></p>"
        },
        {
          "id": 47188,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nifedipine</span></span></p>"
        },
        {
          "id": 47189,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epoprostenol</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 35-year-old female patient with class II pulmonary hypertension presents with a negative vasoreactivity test. Which of the following is used in the next step of management? (INICET NOV 2021)</span></span></span></p>",
      "unique_key": "Q4761503",
      "question_audio": null,
      "question_video": null,
      "map_id": 15935018,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Ambrisentan</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary arterial hypertension (PAH) management depends on the results of the vasoreactivity test. In patients with a negative vasoreactivity test, calcium channel blockers such as nifedipine are not effective. Instead, treatment typically involves the use of endothelin receptor antagonists, phosphodiesterase-5 inhibitors, or prostanoids.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For a patient with WHO functional class II PAH and a negative vasoreactivity test, the next step in management often includes endothelin receptor antagonists like Ambrisentan. Ambrisentan works by blocking the effects of endothelin-1, a potent vasoconstrictor, thereby reducing pulmonary vascular resistance and improving symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Iloprost:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Iloprost is a prostacyclin analog, used primarily in more advanced stages of PAH (class III or IV) or when other treatments have failed. It is not typically the first-line treatment for class II PAH with a negative vasoreactivity test.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Nifedipine:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Nifedipine, a calcium channel blocker, is used in patients with a positive vasoreactivity test. Since this patient has a negative vasoreactivity test, nifedipine is not appropriate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Epoprostenol:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Epoprostenol is another prostacyclin analog used in advanced PAH (class III or IV) or refractory cases. It is not typically used for initial treatment in class II PAH with a negative vasoreactivity test.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In class II and class III pulmonary arterial hypertension (PAH), the best option is to use a combination of a phosphodiesterase inhibitor like Tadalafil and an endothelin receptor antagonist like Ambrisentan. Combination therapy is preferred, even though it may not be listed in all options. For refractory class III and class IV PAH patients, prostanoids are used.</span></span></span></p>",
      "correct_choice_id": 47187,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11699,
      "choices": [
        {
          "id": 46762,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sitagliptin </span></span></span></span></p>"
        },
        {
          "id": 46763,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pioglitazone </span></span></span></span></p>"
        },
        {
          "id": 46764,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Canagliflozin</span></span></span></span></p>"
        },
        {
          "id": 46765,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liraglutide</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A morbidly obese diabetic woman is not responsive to metformin therapy. She has a history of pancreatitis and family history of bladder cancer. She does not want to take injections. Which of the following would be suitable to reduce her glucose levels? (AIIMS NOV 2018)</span></span></span></span></p>",
      "unique_key": "Q3460480",
      "question_audio": null,
      "question_video": null,
      "map_id": 15935019,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Canagliflozin</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Canagliflozin is a suitable oral medication for a diabetic patient not responding to metformin, especially when she has a history of pancreatitis and a family history of bladder cancer, and prefers to avoid injectable medications. Canagliflozin works by inhibiting the sodium-glucose co-transporter 2 (SGLT2), which helps the kidneys excrete glucose through urine, thus lowering blood glucose levels</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Sitagliptin:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Not ideal as it has been associated with a risk of acute pancreatitis, which poses a significant risk given her medical history.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Pioglitazone:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Should be avoided due to its potential link with bladder cancer, especially considering her family history.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Liraglutide:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Although effective in managing diabetes, it is not suitable as it is an injectable medication and the patient prefers to avoid injections. Moreover, it also carries a risk of pancreatitis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In choosing diabetes medications for patients with specific health concerns, it&#39;s crucial to consider both the efficacy and the side-effect profile of the drug, as well as patient preferences for administration methods to ensure compliance and safety. Canagliflozin is an appropriate choice for this patient due to its oral administration and lower risk concerning her medical history.</span></span></span></span></p>",
      "correct_choice_id": 46764,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55367,
      "choices": [
        {
          "id": 220929,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">ARDS</span></span></p>"
        },
        {
          "id": 220930,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Hospital Acquired Pneumonia</span></span></p>"
        },
        {
          "id": 220931,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Community Acquired Pneumonia</span></span></p>"
        },
        {
          "id": 220932,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Aspiration Pneumonia</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A patient had a history of TIA and was admitted. 48 hours later he developed severe respiratory difficulty and fever. What is the probable cause?<strong> </strong>(FMGE JULY 2024)</span></span></p>",
      "unique_key": "Q4029340",
      "question_audio": null,
      "question_video": null,
      "map_id": 15935020,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B) Hospital Acquired Pneumonia</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Hospital-acquired pneumonia (HAP) is defined as pneumonia that occurs 48 hours or more after admission to a hospital and was not present at the time of admission. In this case, the patient developed severe respiratory difficulty and fever 48 hours after being admitted, which fits the definition of HAP. This type of pneumonia is typically caused by bacteria that are more resistant to antibiotics compared to those causing community-acquired pneumonia. Early identification and treatment are crucial for better outcomes.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. ARDS (Acute Respiratory Distress Syndrome):</strong> ARDS can cause severe respiratory difficulty and is often associated with significant illnesses or injuries, but the timeline and presence of fever in this case are more consistent with an infection like pneumonia.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Community Acquired Pneumonia:</strong> This type of pneumonia occurs outside of a healthcare setting or within 48 hours of hospital admission. Given that the symptoms developed 48 hours after admission, it is not classified as community-acquired.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Aspiration Pneumonia:</strong> Aspiration pneumonia occurs when food, liquid, or vomit is inhaled into the lungs, leading to infection. While it can occur in hospitalized patients, the timing and presentation in this case are more suggestive of hospital-acquired pneumonia.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Pneumonia developing 48 hours or more after hospital admission is classified as hospital-acquired pneumonia (HAP).</span></span></p>",
      "correct_choice_id": 220930,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11353,
      "choices": [
        {
          "id": 45378,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antiarrhythmics</span></span></span></p>"
        },
        {
          "id": 45379,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IV NaHCO3</span></span></span></p>"
        },
        {
          "id": 45380,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Propranolol</span></span></span></p>"
        },
        {
          "id": 45381,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Phenytoin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient on antidepressants presented to you with hypotension. An ECG was done, which showed wide QRS complexes and right axis deviation. How will you manage this patient? (Neet pg 2022)</span></span></span></p>",
      "unique_key": "Q1539203",
      "question_audio": null,
      "question_video": null,
      "map_id": 15935021,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. IV NaHCO3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient presents with symptoms indicative of tricyclic antidepressant (TCA) overdose, which includes hypotension, wide QRS complexes, and right axis deviation on the ECG. TCAs can block sodium channels in the heart, leading to QRS widening and the potential for serious arrhythmias. They also have anticholinergic effects, which can contribute to the clinical picture.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The first-line treatment for TCA overdose, especially in the presence of cardiac toxicity such as wide QRS complexes, is intravenous sodium bicarbonate (IV NaHCO3). Sodium bicarbonate works by alkalinizing the blood, which helps to overcome the sodium channel blockade caused by TCAs. It also increases the extracellular sodium concentration, which can help stabilize cardiac cell membranes and improve conduction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Antiarrhythmics</strong>: While antiarrhythmics might be considered in other cases of cardiac arrhythmias, they are not the first-line treatment for TCA overdose. In fact, some antiarrhythmic drugs can worsen the condition by further blocking sodium channels or prolonging the QT interval.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Propranolol</strong>: Propranolol is a beta-blocker used to treat high blood pressure and certain types of arrhythmias. However, it is not indicated for the treatment of TCA toxicity and can potentially exacerbate hypotension and cardiac conduction abnormalities.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Phenytoin</strong>: Phenytoin is an anticonvulsant that can also be used for certain types of arrhythmias. However, it is not effective in treating the sodium channel blockade caused by TCAs and is not recommended for managing TCA overdose.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The primary treatment for tricyclic antidepressant overdose, especially when presenting with wide QRS complexes and right axis deviation, is intravenous sodium bicarbonate (IV NaHCO3).</span></span></p>",
      "correct_choice_id": 45379,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50966,
      "choices": [
        {
          "id": 203405,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Addison&#39;s disease&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203406,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gigantism&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203407,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acromegaly</span></span></span></span></p>"
        },
        {
          "id": 203408,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cushing&#39;s syndrome&nbsp;</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These findings are suggestive of which of the following conditions</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-113157.png\" style=\"height:174px; width:300px\" /></span></span></p>",
      "unique_key": "Q2208116",
      "question_audio": null,
      "question_video": null,
      "map_id": 15935022,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">) <strong>Acromegaly</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: &nbsp;</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The images provided show a patient with coarse facial features, prognathism (protruding jaw), frontal bossing (prominent forehead), and prominent jaw bones. These are characteristic features of acromegaly, a condition caused by excessive growth hormone (GH) production, usually due to a pituitary adenoma.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Addison&#39;s disease:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Characterized by hyperpigmentation, hypotension, and weight loss, not by coarse facial features.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Gigantism:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Also caused by excess GH, but it occurs before the closure of the growth plates in children and adolescents, leading to increased height and growth of long bones. The facial features are not as prominent as in acromegaly.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Cushing&#39;s syndrome:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Characterized by features such as central obesity, moon face, buffalo hump, and purple striae, not by coarse facial features and prognathism.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acromegaly is diagnosed based on characteristic facial features such as coarse facial features, prognathism, and frontal bossing, resulting from excessive growth hormone production.</span></span></p>",
      "correct_choice_id": 203407,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 66111,
      "choices": [
        {
          "id": 263589,
          "text": "<p><span style=\"font-size:12.0pt;\">Sudden-onset severe headache</span></p>"
        },
        {
          "id": 263590,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypertension</span></p>"
        },
        {
          "id": 263591,
          "text": "<p><span style=\"font-size:12.0pt;\">Fatigue</span></p>"
        },
        {
          "id": 263592,
          "text": "<p><span style=\"font-size:12.0pt;\">Weight gain</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a characteristic early symptom of pituitary apoplexy? <i>(Twisted PYQ)</i></span></p>",
      "unique_key": "Q5402116",
      "question_audio": null,
      "question_video": null,
      "map_id": 15935023,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Sudden-onset severe headache</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Pituitary apoplexy</strong> refers to the acute hemorrhage or infarction of the pituitary gland, often occurring in a pre-existing pituitary adenoma. It is a medical emergency, and the <strong>sudden-onset severe headache</strong> is a hallmark early symptom, often described as \"thunderclap\" in nature. Additional features may include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Visual disturbances:</strong> Due to compression of the optic chiasm.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Nausea and vomiting:</strong> Resulting from increased intracranial pressure.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Shock:</strong> Secondary to acute adrenal insufficiency caused by pituitary hormonal dysfunction.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Altered mental status or unconsciousness:</strong> Seen in severe cases with significant intracranial pressure or hemorrhage.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">MRI is the diagnostic modality of choice, and management involves urgent IV glucocorticoids and, if necessary, surgical decompression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hypertension:</strong> Incorrect because hypotension or shock, rather than hypertension, is typically seen in pituitary apoplexy due to adrenal insufficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Fatigue:</strong> Incorrect because fatigue is a chronic symptom associated with hypopituitarism and not an acute presentation of pituitary apoplexy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Weight gain:</strong> Incorrect because weight gain is not an acute symptom and is more commonly associated with chronic hormonal dysfunction like Cushingâs disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Sudden-onset severe headache is the hallmark early symptom of pituitary apoplexy. Recognizing this and associated symptoms such as visual disturbances and shock is critical for prompt diagnosis and treatment, which may include IV glucocorticoids and surgical intervention. Early management prevents life-threatening complications.</span></p>",
      "correct_choice_id": 263589,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11503,
      "choices": [
        {
          "id": 45978,
          "text": "<p><span style=\"font-size:12.0pt;\">Flexor tenosynovitis</span></p>"
        },
        {
          "id": 45979,
          "text": "<p><span style=\"font-size:12.0pt;\">Dupuytrens contracture</span></p>"
        },
        {
          "id": 45980,
          "text": "<p><span style=\"font-size:12.0pt;\">Cheiroarthropathy</span></p>"
        },
        {
          "id": 45981,
          "text": "<p><span style=\"font-size:12.0pt;\">Ankyloses</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A diabetic patient walks into your clinic and does \"namaste\". The image is given below. What could be the probable cause? (AIIMS MAY 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/nm78.jpg\" alt=\"\" width=\"300\" height=\"281\"></span></p>",
      "unique_key": "Q3819235",
      "question_audio": null,
      "question_video": null,
      "map_id": 15935024,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C)&nbsp;Cheiroarthropathy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Incomplete approximation of one or more of the digits when the patient attempts to approximate the palmar surfaces of the proximal and distal interphalangeal joints with palms pressed together and the fingers abducted.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It is associated with <strong>both Microvascular disease and macrovascular risk</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Flexor tenosynovitis:&nbsp;</strong>Involves inflammation of the tendon sheaths and is typically painful, which might include swelling and crepitus upon movement. It does not typically present with the inability to approximate the palms as in cheiroarthropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Dupuytren's contracture:&nbsp;</strong>Results in fibrosis of the palmar fascia leading to permanent bending of the fingers into the palm. Unlike cheiroarthropathy, Dupuytren's typically produces visible nodules and cords in the palm, pulling the fingers inward.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Ankylosis:&nbsp;</strong>Involves the complete fusion of a joint leading to total immobility. This would manifest as rigid, immovable joints in fixed positions, not merely stiff and difficult to approximate as in cheiroarthropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cheiroarthropathy is a significant indicator of chronic diabetic complications affecting the connective tissue. Recognizing this condition is important as it often correlates with other microvascular complications of diabetes such as retinopathy and nephropathy, prompting comprehensive management of the patient's diabetes to prevent further complications.</span></p>",
      "correct_choice_id": 45980,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11332,
      "choices": [
        {
          "id": 45294,
          "text": "<p><span style=\"font-size:12.0pt;\">pH- 7.14, pCO2- 20 mm Hg, HCO3-5 mEq/L</span></p>"
        },
        {
          "id": 45295,
          "text": "<p><span style=\"font-size:12.0pt;\">pH- 7.14, pCO2- 20 mm Hg, HCO3- 34 mEq/L</span></p>"
        },
        {
          "id": 45296,
          "text": "<p><span style=\"font-size:12.0pt;\">pH - 7.54, HCO3 - 27 mEq/L, pCO2-34 mm Hg</span></p>"
        },
        {
          "id": 45297,
          "text": "<p><span style=\"font-size:12.0pt;\">pH- 7.4, HCO3 - 27 mEq/L, pCO2- 40 mm Hg</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A middle-aged man with chronic renal failure on dialysis presents with sudden collapse to the casualty with labored breathing. ECG shows tall tented T waves. What is the most likely acid-base imbalance that can be seen in this patient?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(NEET PG 2021)</span></p>",
      "unique_key": "Q4172286",
      "question_audio": null,
      "question_video": null,
      "map_id": 15935025,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. pH- 7.14, pCO2- 20 mm Hg, HCO3-5 mEq/L</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient with chronic renal failure presenting with sudden collapse and labored breathing is indicative of a severe acid-base disturbance, most likely <strong>metabolic acidosis.</strong> The tall tented T waves on the ECG suggest hyperkalemia, a common finding in metabolic acidosis and renal failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Patients with chronic renal failure often have a <strong>high anion gap</strong> metabolic acidosis due to the accumulation of uremic toxins. The lab values in pH - 7.14, pCO2 - 20 mm Hg, HCO3 - 5 mEq/L indicate a severe metabolic acidosis with respiratory compensation. The low bicarbonate level confirms metabolic acidosis, and the low pCO2 indicates compensatory hyperventilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. pH- 7.14, pCO2- 20 mm Hg, HCO3- 34 mEq/L:</strong> This combination is inconsistent with metabolic acidosis because the bicarbonate level is high, which would not be seen in metabolic acidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. pH - 7.54, HCO3 - 27 mEq/L, pCO2-34 mm Hg:</strong> This represents metabolic alkalosis or compensated respiratory acidosis, neither of which are consistent with the clinical picture of chronic renal failure and hyperkalemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. pH- 7.4, HCO3 - 27 mEq/L, pCO2- 40 mm Hg:</strong> This reflects a normal pH, which would not be seen in the acute setting described, especially with the presence of severe symptoms and hyperkalemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Patients with chronic renal failure are at risk for high anion gap metabolic acidosis. In cases of sudden collapse with labored breathing and ECG changes like tall tented T waves, metabolic acidosis with compensatory respiratory alkalosis is the most likely diagnosis.</span></p>",
      "correct_choice_id": 45294,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11868,
      "choices": [
        {
          "id": 47438,
          "text": "<p><span style=\"font-size:12.0pt;\">Metoprolol</span></p>"
        },
        {
          "id": 47439,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        },
        {
          "id": 47440,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenosine</span></p>"
        },
        {
          "id": 47441,
          "text": "<p><span style=\"font-size:12.0pt;\">Diltiazem</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Based on the ECG given below, which of the following drugs is NOT used in the management of the condition? (INICET NOV 2022)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/whatsapp-image-2024-09-13-at-103835-am.jpeg\" alt=\"\" width=\"300\" height=\"164\"></p>",
      "unique_key": "Q9844721",
      "question_audio": null,
      "question_video": null,
      "map_id": 15935026,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Adenosine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The ECG shows a case of <strong>atrial fibrillation</strong>, characterized by an irregularly irregular rhythm and the absence of distinct P waves. Instead, there are fibrillatory waves that can be seen in the baseline. Atrial fibrillation is a common type of irregular heart rhythm where the atria beat chaotically and irregularly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Adenosine is not used in the management of atrial fibrillation. It is primarily indicated for the treatment of regular narrow complex tachycardias, such as supraventricular tachycardia (SVT). Adenosine works by temporarily blocking the atrioventricular (AV) node, which can help reset the heart rhythm in cases of regular tachycardias. However, in irregular rhythms like atrial fibrillation, adenosine is contraindicated because it can induce atrial fibrillation or exacerbate the condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Metoprolol:</strong> Metoprolol is a beta-blocker used in the management of atrial fibrillation. It helps control the heart rate by slowing down the conduction through the AV node.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Amiodarone:</strong> Amiodarone is an antiarrhythmic medication used for rhythm control in atrial fibrillation. It can help to convert atrial fibrillation to a normal sinus rhythm and maintain it.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Diltiazem:</strong> Diltiazem is a calcium channel blocker used to control the ventricular rate in atrial fibrillation by slowing conduction through the AV node.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Adenosine should not be used in the management of atrial fibrillation due to its potential to induce or worsen the condition.</span></p>",
      "correct_choice_id": 47440,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 66112,
      "choices": [
        {
          "id": 263593,
          "text": "<p><span style=\"font-size:12.0pt;\">Extravascular hemolysis</span></p>"
        },
        {
          "id": 263594,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravascular hemolysis</span></p>"
        },
        {
          "id": 263595,
          "text": "<p><span style=\"font-size:12.0pt;\">Autoimmune-mediated hemolysis</span></p>"
        },
        {
          "id": 263596,
          "text": "<p><span style=\"font-size:12.0pt;\">Enzyme deficiency-mediated hemolysis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the primary mechanism of hemolysis in paroxysmal nocturnal hemoglobinuria (PNH)? <i>(Twisted PYQ)</i></span></p>",
      "unique_key": "Q3234043",
      "question_audio": null,
      "question_video": null,
      "map_id": 15935027,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Intravascular hemolysis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">In <strong>paroxysmal nocturnal hemoglobinuria (PNH),</strong> intravascular hemolysis occurs due to the destruction of red blood cells within the circulation. This is caused by:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Deficiency of CD55 and CD59:</strong> These proteins protect red blood cells from complement-mediated destruction. In PNH, a mutation in the <strong>PIG-A gene</strong> results in the absence of glycosylphosphatidylinositol (GPI)-anchored proteins, including CD55 and CD59.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Complement activation:</strong> Leads to uncontrolled lysis of red blood cells directly within blood vessels, resulting in hemoglobinuria, anemia, and other complications like thrombosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Extravascular hemolysis:</strong> Incorrect because PNH primarily involves intravascular hemolysis due to complement activation. Extravascular hemolysis occurs in conditions like hereditary spherocytosis, where red blood cells are destroyed in the spleen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Autoimmune-mediated hemolysis:</strong> Incorrect because PNH is not autoimmune in nature. It is caused by an acquired somatic mutation in hematopoietic stem cells, not an immune system attack involving autoantibodies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Enzyme deficiency-mediated hemolysis:</strong> Incorrect because PNH is not due to an enzymatic defect like glucose-6-phosphate dehydrogenase (G6PD) deficiency, which causes hemolysis after oxidative stress.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Paroxysmal nocturnal hemoglobinuria (PNH) is characterized by intravascular hemolysis due to complement-mediated destruction of red blood cells lacking CD55 and CD59. The hallmark feature of PNH is hemoglobinuria, often leading to anemia and thrombotic complications. Prompt recognition and treatment with complement inhibitors like eculizumab are critical for improving outcomes.</span></p>",
      "correct_choice_id": 263594,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54273,
      "choices": [
        {
          "id": 216561,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pioglitazone</span></span></p>"
        },
        {
          "id": 216562,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sitagliptin</span></span></p>"
        },
        {
          "id": 216563,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glimepiride</span></span></p>"
        },
        {
          "id": 216564,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metformin</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following drugs used in the management of diabetes is associated with unexplained diarrhea?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q2343755",
      "question_audio": null,
      "question_video": null,
      "map_id": 15935048,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Metformin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metformin is a biguanide used as a first-line treatment for type 2 diabetes mellitus. One of the most common and significant side effects of metformin is gastrointestinal disturbances, particularly diarrhea. This side effect is due to the drug&rsquo;s effect on the gastrointestinal tract, which can cause alterations in bowel habits, including watery diarrhea.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Pioglitazone:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This drug is a thiazolidinedione and is not typically associated with diarrhea. Its side effects include fluid retention, weight gain, and an increased risk of bladder cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Sitagliptin:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. While it can cause gastrointestinal side effects, it is more commonly associated with symptoms like indigestion, nausea, and bloating rather than diarrhea.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Glimepiride:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Glimepiride is a sulfonylurea and is generally not associated with diarrhea. Its side effects typically include hypoglycemia and weight gain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metformin is commonly associated with unexplained diarrhea as a side effect, making it important for healthcare providers to monitor patients for this gastrointestinal disturbance when prescribing the medication.</span></span></span></p>",
      "correct_choice_id": 216564,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47620,
      "choices": [
        {
          "id": 190091,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute Myeloid Leukemia</span></p>"
        },
        {
          "id": 190092,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic Myeloid Leukemia</span></p>"
        },
        {
          "id": 190093,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic Lymphocytic Leukemia</span></p>"
        },
        {
          "id": 190094,
          "text": "<p><span style=\"font-size:12.0pt;\">Sickle cell anemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old female patient with early satiety, bleeding and on examination, patient has spleen palpable till umbilicus. WBC count is 85,000/mmÂ³ with immature WBCs seen in the peripheral blood smear. What is the diagnosis? (</span>FMGE Jan 2024)</p>",
      "unique_key": "Q1547419",
      "question_audio": null,
      "question_video": null,
      "map_id": 15935049,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Chronic Myeloid Leukemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct answer is Chronic Myeloid Leukemia (CML). The patient presents with massive splenomegaly, early satiety, bleeding, and a significantly elevated white blood cell (WBC) count of 85,000/mmÂ³ with immature WBCs in the peripheral smear. These features are characteristic of CML, a type of leukemia where the bone marrow makes too many white blood cells. The presence of immature WBCs (a left shift) and massive splenomegaly are classic signs of CML.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Acute Myeloid Leukemia (AML):&nbsp;</strong>While AML also involves immature WBCs, it usually presents more acutely and with less pronounced splenomegaly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Diagnosed if â</strong> Myeloid blast count <u>&gt;20%;&nbsp; APL (t15:17); CBF (t8:21; t16:16 inversion 16)</u></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Chronic Lymphocytic Leukemia (CLL):&nbsp;</strong>CLL typically presents with a high number of mature lymphocytes rather than <strong>immature WBCs</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Sickle cell anemia:&nbsp;</strong>This condition is unlikely in a 60-year-old due to <strong>autosplenectomy</strong> typically occurring by age 3-4, making splenomegaly in this age group highly unlikely. Moreover, the WBC count in sickle cell anemia is not usually elevated to this extent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CML should be suspected in patients presenting with massive splenomegaly, significantly elevated WBC count, and immature WBCs on peripheral smear. Recognizing these signs can prompt further diagnostic evaluation, including the detection of the Philadelphia chromosome (BCR-ABL fusion gene).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CML ideally Diagnosed as â Blast count &lt;20% + Philadelphia +ve + Left shift in PS (lots of immature WBC)</span></p>",
      "correct_choice_id": 190092,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55368,
      "choices": [
        {
          "id": 220933,
          "text": "<p><span style=\"font-size:12pt;\">Hollow viscus perforation</span></p>"
        },
        {
          "id": 220934,
          "text": "<p><span style=\"font-size:12pt;\">Everted hemidiaphragm</span></p>"
        },
        {
          "id": 220935,
          "text": "<p><span style=\"font-size:12pt;\">Intestinal obstruction</span></p>"
        },
        {
          "id": 220936,
          "text": "<p><span style=\"font-size:12pt;\">Hyperinflated lungs</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">What is the diagnosis based on the Chest X Ray? &nbsp;(FMGE JULY 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/30/screenshot-2024-08-30-103618.png\" alt=\"\" width=\"300\" height=\"303\"></span></p>",
      "unique_key": "Q9921077",
      "question_audio": null,
      "question_video": null,
      "map_id": 15935050,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Hollow viscus perforation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The chest X-ray shows a clear sign of air under the diaphragm, which is a classic radiographic finding indicating a hollow viscus perforation. This condition typically results from the perforation of any part of the gastrointestinal tract, such as the stomach, intestines, or colon, leading to the escape of air into the peritoneal cavity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The key diagnostic clue in the X-ray is the presence of free air under the diaphragm, which appears as a crescent of radiolucency (dark area) beneath the dome of the diaphragm. This finding is an emergency and requires immediate medical intervention.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Everted hemidiaphragm:</strong> This condition would not present with free air under the diaphragm. Instead, it involves the abnormal elevation of one side of the diaphragm due to various causes such as phrenic nerve paralysis, but does not produce the characteristic air under the diaphragm seen in this X-ray.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Intestinal obstruction:</strong> While this condition can cause significant abdominal pain and distension, it does not typically result in the presence of free air under the diaphragm on a chest X-ray. Instead, intestinal obstruction is diagnosed via abdominal X-rays or CT scans showing dilated bowel loops and air-fluid levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Hyperinflated lungs:</strong> This is usually seen in chronic obstructive pulmonary disease (COPD) and would show an increased lung volume and flattened diaphragms on the X-ray, but not free air under the diaphragm.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The presence of free air under the diaphragm on a chest X-ray is a hallmark sign of a hollow viscus perforation, which is a surgical emergency</span></p>",
      "correct_choice_id": 220933,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "FMGE",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11333,
      "choices": [
        {
          "id": 45298,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchial asthma</span></span></p>"
        },
        {
          "id": 45299,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Miliary tuberculosis</span></span></p>"
        },
        {
          "id": 45300,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tropical pulmonary eosinophilia</span></span></p>"
        },
        {
          "id": 45301,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypersensitivity pneumonitis</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient presents with fever, nocturnal cough, breathlessness, and wheezing for 4 weeks. Absolute eosinophil count &gt; 5000/&mu;L. Chest X-ray shows a miliary pattern. What is the likely diagnosis?</span> <span style=\"font-size:12.0pt\">(NEET PG 2021)</span></span></span></p>",
      "unique_key": "Q9816918",
      "question_audio": null,
      "question_video": null,
      "map_id": 15935051,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C. Tropical pulmonary eosinophilia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tropical pulmonary eosinophilia (TPE) is a condition caused by the presence of microfilariae in the pulmonary circulation, leading to a severe immune response characterized by significant eosinophilia. The clinical presentation includes fever, nocturnal cough, breathlessness, and wheezing, which are symptoms consistent with TPE. The absolute eosinophil count greater than 5000/&mu;L further supports this diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The chest X-ray finding of a miliary pattern, though more commonly associated with tuberculosis, can also be seen in TPE due to the diffuse infiltration of eosinophils in the lungs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Bronchial asthma:</span></strong><span style=\"font-size:12.0pt\"> Asthma can present with wheezing and nocturnal symptoms but is not typically associated with a miliary pattern on chest X-ray or such a high level of eosinophilia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Miliary tuberculosis:</span></strong><span style=\"font-size:12.0pt\"> Miliary tuberculosis can present with a miliary pattern on chest X-ray but is not associated with a significantly elevated eosinophil count. Miliary TB usually presents with systemic symptoms like weight loss, night sweats, and widespread dissemination in the body.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hypersensitivity pneumonitis:</span></strong><span style=\"font-size:12.0pt\"> This condition can cause pulmonary symptoms and may present with a miliary pattern on imaging. However, it is usually a type III hypersensitivity reaction (immune complex-mediated) and does not typically lead to such high levels of eosinophilia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tropical pulmonary eosinophilia is characterized by symptoms like fever, nocturnal cough, breathlessness, wheezing, significant eosinophilia, and a miliary pattern on chest X-ray. This diagnosis should be considered in patients presenting with these clinical findings, especially in endemic regions. The treatment of choice for TPE is diethylcarbamazine (DEC).</span></span></p>",
      "correct_choice_id": 45300,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 66113,
      "choices": [
        {
          "id": 263597,
          "text": "<p><span style=\"font-size:12.0pt;\">Stop methotrexate and initiate leflunomide</span></p>"
        },
        {
          "id": 263598,
          "text": "<p><span style=\"font-size:12.0pt;\">Add an anti-TNF alpha agent to the current regimen</span></p>"
        },
        {
          "id": 263599,
          "text": "<p><span style=\"font-size:12.0pt;\">Start parenteral corticosteroids and continue methotrexate</span></p>"
        },
        {
          "id": 263600,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase methotrexate dose and monitor for response</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with rheumatoid arthritis is being treated with methotrexate and low-dose corticosteroids for the past 4 months. Despite this, the disease is progressing with worsening symptoms and joint damage evident on imaging. What would be your recommendation for the further management of this patient? (Twisted PYQ)</span></p>",
      "unique_key": "Q5435578",
      "question_audio": null,
      "question_video": null,
      "map_id": 15935052,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Add an anti-TNF alpha agent to the current regimen</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For patients with rheumatoid arthritis who show inadequate response to methotrexate and low-dose corticosteroids after an adequate trial period, escalation of therapy is necessary. Anti-TNF alpha agents, such as infliximab, adalimumab, or etanercept, are potent biologic DMARDs that target key inflammatory pathways in rheumatoid arthritis. Adding an anti-TNF agent to methotrexate improves efficacy, reduces joint damage, and enhances overall disease control.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Stop methotrexate and initiate leflunomide</strong>: Switching from methotrexate to leflunomide may be an option in cases of methotrexate intolerance or contraindication, but it is not the preferred step in patients tolerating methotrexate who need better disease control.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Start parenteral corticosteroids and continue methotrexate</strong>: Parenteral corticosteroids may offer temporary relief but do not address long-term disease progression or modify disease activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Increase methotrexate dose and monitor for response</strong>: Methotrexate dosing is typically maximized before considering additional therapies. If the patient is already on an optimal dose, adding another agent is warranted.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cases of inadequate response to methotrexate and corticosteroids in rheumatoid arthritis, biologic agents like anti-TNF alpha inhibitors are effective and commonly used next steps. These agents can significantly improve disease outcomes by targeting specific cytokines involved in the pathogenesis of rheumatoid arthritis. Early intervention with biologics can prevent irreversible joint damage and disability.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference</strong>: Harrison/Rheumatoid Arthritis/Chapter 358</span></p>",
      "correct_choice_id": 263598,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11334,
      "choices": [
        {
          "id": 45302,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diabetic ketoacidosis</span></span></p>"
        },
        {
          "id": 45303,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Persistent vomiting</span></span></p>"
        },
        {
          "id": 45304,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Septic shock</span></span></p>"
        },
        {
          "id": 45305,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal tubular acidosis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Arterial blood gas (ABG) report shows the following findings:</span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2021)</span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">pH: 7.52</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">HCO3: 30 mEq/L</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">PaCO2: 45 mmHg</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Na: 123 mEq/L</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">K: 3.2 mEq/L</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cl: 67 mEq/L</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the cause of her ABG findings? </span></span></p>",
      "unique_key": "Q1753141",
      "question_audio": null,
      "question_video": null,
      "map_id": 15935053,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B. Persistent vomiting</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The ABG report indicates the patient has <strong>metabolic alkalosis</strong>, as evidenced by the elevated pH (7.52) and increased bicarbonate (HCO3) level (30 mEq/L). The slight increase in PaCO2 (45 mmHg) is a compensatory response to metabolic alkalosis, as the body attempts to retain CO2 to balance the pH.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Persistent vomiting leads to a loss of gastric acid (HCl), which results in metabolic alkalosis. The electrolyte disturbances seen here (hypokalemia, hypochloremia, and hyponatremia) are typical of persistent vomiting. Vomiting causes a loss of hydrogen ions (leading to increased bicarbonate), chloride (hypochloremia), and potassium (hypokalemia), along with fluid loss, which can dilute serum sodium levels, leading to hyponatremia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Diabetic ketoacidosis:</span></strong><span style=\"font-size:12.0pt\"> Diabetic ketoacidosis (DKA) typically presents with metabolic acidosis (low pH and low HCO3) rather than metabolic alkalosis. Additionally, DKA is usually associated with hyperkalemia rather than hypokalemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Septic shock:</span></strong><span style=\"font-size:12.0pt\"> Septic shock usually causes metabolic acidosis due to lactic acidosis from poor tissue perfusion. It does not typically present with metabolic alkalosis and the specific electrolyte disturbances seen here.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Renal tubular acidosis:</span></strong><span style=\"font-size:12.0pt\"> Renal tubular acidosis (RTA) is characterized by a defect in the kidneys&#39; ability to acidify the urine, leading to metabolic acidosis. The ABG findings in RTA would show a low pH and low bicarbonate levels, which is opposite to what is observed in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Persistent vomiting can lead to hypokalemic, hypochloremic metabolic alkalosis with hyponatremia. This is due to the loss of gastric acid and electrolytes, and the characteristic ABG findings include elevated pH and bicarbonate levels. Treatment often involves fluid and electrolyte replacement, particularly with normal saline to correct chloride levels.</span></span></p>",
      "correct_choice_id": 45303,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}